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1 Summary 
 
STIM, ORAI and some TRP proteins are believed to participate in store-operated 
Ca2+ entry (SOCE). The calcium-release activated calcium (CRAC) channels 
represent the best characterized SOCE pathway in non-excitable cells. First 
described in immune cells, CRAC channels were shown to play an important role in 
the Ca2+ signalling pathway for T cell activation and differentiation but the molecular 
components of the CRAC channels remained enigmatic for a long time. Recently, 
crucial experiments attracted the attention to the stromal-interacting molecule 1 
(STIM1) and ORAI (CRACM) proteins as central components of CRAC channels. 
Furthermore, the non-selective TRPC5 ion channels were reported to play a role in 
SOCE and they were also discussed as receptor-activated ion channels. Despite 
intensive research with recombinant TRPC5 ion channels, however, little is known 
about their possible functional role and their activation mechanism is still discussed 
controversially. 
In this thesis, I explore the following issues: 
 
1. Murine STIM1 and ORAI proteins: Role in the formation and activation of 
CRAC channels. 
  
2. TRPC5 ion channels: Activation mechanisms and coupling to Ca2+-selective 
ion channels. 
 
Four different murine ORAI variants were cloned and functionally studied in 
electrophysiological experiments. Here, it is shown that murine ORAI1, ORAI2L, 
ORAI2S and ORAI2S (N130Y) form functional CRAC channels which are activated 
via STIM1 translocation to the plasma membrane in response to store-depletion. 
Murine ORAI proteins seem to form multimeric complexes to establish functional 
Ca2+-selective ion channels both as homo- and heteromultimeric assemblies. Since 
ORAI variants differing in N-terminus length generate distinct current densities, the  
N-terminus of ORAI proteins apparently plays a critical role in ion channel gating. In 
HEK 293 cells, for instance, STIM1 plus the long variant of ORAI2 generate larger 
current densities than STIM1 plus the short variant of ORAI2. According to the 
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reported SCID mutation in human ORAI1, a single point mutation was introduced at 
the N-terminus of the murine ORAI variants. This mutation prevented CRAC current 
activation in response to Ca2+-store depletion, demonstrating the importance of the 
N-terminal amino acid sequence for proper CRAC channel function. In summary, this 
thesis demonstrates that murine ORAI variants form functional CRAC channels by a 
multimeric assembly of ORAI proteins. In the presence of STIM1, these channels 
activate in response to store-depletion, showing inward-rectifying, Ca2+-selective 
currents as originally described for CRAC currents.  
  
Using transient transfections and a cell line stably expressing TRPC5, the activation 
mechanisms of TRPC5 ion channels were systematically studied. Here, it is shown 
that TRPC5 channels are not typically store-operated but, independently from the 
Ca2+-source, they activate upon a local rise of internal Ca2+. In addition, TRPC5 
channels do not appear to directly interact with the STIM1/ORAI1 complex, which is 
responsible for SOCE. The local Ca2+ influx through CRAC channels was observed to 
activate TRPC5 currents and, moreover, additional experiments with  
L-type Ca2+ channels revealed a functional coupling of TRPC5 and Ca2+-selective ion 
channels. Upon Ca2+-entry through CRAC channels, the non-selective TRPC5 
channels activate and the cell membrane depolarizes. Further experiments provided 
evidence that TRPC5 channels are dose-dependently activated by a local rise of 
cytosolic Ca2+. Thus, Ca2+ alone activates TRPC5 channels in a dose-dependent 
manner, indicating that TRPC5 channels might function as Ca2+-activated non-
selective ion channels. Based on these experiments, a novel model is proposed in 
which Ca2+-activated TRPC5 channels may modulate Ca2+ signals by regulating the 
membrane potential and, consequently, the Ca2+ driving force.  
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Zusammenfassung 
 
STIM-, ORAI- und einigen TRP-Proteinen wird in der Literatur eine wichtige Funktion 
für die Speicher-aktivierten Kalzium-Ströme (SOCE) eingeräumt. Die am besten 
beschriebene Untergruppe sind die so genannten CRAC- („calcium-release activated 
calcium“) Ströme. Ursprünglich wurden die CRAC-Ströme in Immunzellen entdeckt 
und es wurde gezeigt, dass sie eine wichtige Rolle bei der T-Zell-Aktivierung und  
-Differenzierung spielen. Die molekularen Bausteine, die für CRAC-Kanäle 
verantwortlich sind, konnten über einen langen Zeitraum nicht identifiziert werden. In 
den letzten Jahren jedoch wurde durch aufschlussreiche Forschungsergebnisse die 
Aufmerksamkeit auf die STIM1- (Stromal-interacting molecule 1) und ORAI-Proteine 
(CRACM-Proteine) gelenkt. Darüber hinaus wurden die nicht-selektiven TRPC5-
Ionenkanäle sowohl als SOCE-Ionenkanäle als auch als Rezeptor-aktivierte 
Ionenkanäle beschrieben. Obwohl die Ionenkanaleigenschaften in TRPC5-
Überexpressionssystemen ausgiebig erforscht wurden, besteht kein fundiertes 
Wissen über die Funktion von TRPC5-Ionenkanälen und die Mechanismen zur 
Kanalaktivierung werden kontrovers diskutiert.  
Von daher wurden in der vorliegenden Arbeit folgende Schwerpunkte untersucht: 
 
1. STIM1- und ORAI-Proteine aus der Maus: Erforschung der Funktion für die 
Aktivierung und die Bildung der CRAC-Ionenkanäle.   
 
2. TRPC5-Ionenkanäle: Untersuchung des Aktivierungsmechanismus und ihre 
funktionelle Interaktion mit Ca2+-selektiven Ionenkanälen. 
 
Für die vorliegende Arbeit wurden ORAI-Proteine aus der Maus kloniert und in 
elektrophysiologischen Experimenten untersucht. Es wird hier gezeigt, dass die 
murinen ORAI1-, ORAI2L-, ORAI2S- und ORAI2S-(N130Y) Varianten funktionelle  
Ca2+-selektive Ionenkanäle bilden, die durch die Translokation der STIM1-Proteine, 
hervorgerufen durch die Entleerung der Ca2+-Speicher, aktiviert werden. Die 
funktionellen ORAI-Proteinkomplexe bestehen wahrscheinlich aus vier ORAI-
Untereinheiten, wobei sowohl homo- als auch heteromultimere Proteinkomplexe 
selektive Ca2+-Ströme leiten. Die Größe der Stromdichte ist von den Ionenkanal-
bildenden ORAI-Varianten abhängig, da der N-Terminus eine wichtige Rolle 
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bezüglich der Ionenkanalaktivität spielt. Die N-terminal längere Variante des ORAI2-
Proteins erzeugt größere Stromdichten als die verkürzte ORAI2-Variante. Der 
Einfluss des N-Terminus wird in immundefizienten SCID-Patienten deutlich, denen, 
durch einen einzelnen Aminosäureaustausch am N-Terminus des ORAI1-Proteins, 
der Ca2+-Einstrom durch den CRAC-Ionenkanal fehlt. Gemäß dieser humanen ORAI-
Mutationen wurden die murinen ORAI-Scid-Proteine generiert und funktionell 
untersucht.  Zusammenfassend beschreibt die vorliegende Arbeit die murinen ORAI-
Varianten als die molekularen Bausteine der CRAC-Ionenkanäle, die aus mehreren 
ORAI-Proteinen gebildet werden. In der Anwesenheit von STIM1 werden diese 
Kanäle durch die Entleerung der Kalziumspeicher aktiviert und weisen die typischen 
Charakteristika von CRAC-Strömen auf. 
 
Außerdem wird der Aktivierungsmechanismen von TRPC5-Kanälen in dieser Arbeit 
systematisch untersucht. Es wird gezeigt, dass diese Ionenkanäle keine typischen 
Speicher-aktivierten Kanäle sind, jedoch allein durch einen lokalen Kalziumanstieg 
aktiviert werden. Ebenso wird untersucht, ob TRPC5 mit STIM1- und ORAI-Proteinen 
interagiert, die für den Speicher-aktivierten Ca2+-Einstrom verantwortlich sind. Eine 
direkte Interaktion wurde nicht festgestellt, jedoch aktivieren TRPC5-Ströme, sobald 
Ca2+ durch CRAC-Kanäle in die Zelle einströmt. Ca2+-Einstrom durch L-Typ-Ca2+-
Kanäle führt ebenfalls zur Aktivierung der TRPC5-Ionenkanäle. Es besteht somit eine 
funktionelle Interaktion zwischen TRPC5- und Ca2+-selektiven Ionenkanälen. Durch 
den Ca2+-Einstrom werden die nicht-selektiven TRPC5-Ionenkanäle aktiviert, was zur 
Depolarisation der Zellmembran führt und den CRAC- oder spannungsabhängigen 
Ca2+-Kanal-abhängigen Ca2+-Einstrom hemmt. Weitere Experimente zeigen, dass 
TRPC5-Ionenkanäle durch erhöhte intrazelluläre Ca2+-Konzentrationen dosis-
abhängig aktiviert werden. Somit wird postuliert, dass die nicht-selektiven  
Ca2+-aktivierten TRPC5-Ionenkanäle den Ca2+-Einstrom durch CRAC-Kanäle oder  
L-Typ-Ca2+-Kanäle modulieren, da durch die Aktivierung der TRPC5-Ionenkanäle 
das Membranpotential steigt und davon abhängig auch der elektrochemische 
Gradient für Ca2+ sinkt.  
        
  
 8
2 Introduction 
 
Calcium (Ca2+) signalling controls a vast array of cellular functions in the anatomy, 
physiology and biochemistry of an organism. These functions range from short-term 
responses, such as muscle contraction and neurotransmitter secretion, to long-term 
regulation of cell growth and proliferation. At the cellular level, Ca2+ is derived from 
two sources – the extracellular space and intracellular Ca2+ stores such as the 
endoplasmatic or sarcoplasmatic reticulum1. For precise Ca2+ signalling, the 
intracellular Ca2+ concentration must be accurately controlled with respect to space2, 
time3 and amplitude4. In excitable cells, the major pathway for Ca2+ influx is via Ca2+-
selective voltage-gated Ca2+ channels (VGCC) whereas, in non-excitable cells, Ca2+ 
influx is mediated via SOCE (store-operated Ca2+ entry) channels or triggered by 
receptor stimulation, named as receptor-operated Ca2+ entry (ROCE). The best 
characterized SOCE is the Ca2+ release-activated Ca2+ current hereafter referred to 
as CRAC current or ICRAC5. Firstly described in 1992, the molecular components of 
ICRAC remained elusive until the Ca2+-sensor STIM16, 7 (stromal interaction molecule) 
and ORAI1 / CRACM18-10 proteins were reported to reconstitute the CRAC current11, 
12. Additionally, it has also been suggested that, in overexpression systems, transient 
receptor potential ion channels (TRPCs) might form SOCE ion channels13-15. 
Here I report that the murine ORAI1, ORAI2L and ORAI2S form functional CRAC 
channels in HEK 293 or RBL 2H3 cells. In addition, I show that TRPC ion channels 
are activated in response to local Ca2+ influx carried by CRAC currents and Ca2+ 
influx through voltage-gated Ca2+ channels (VGCC) in HEK 293 cells overexpressing 
STIM1 and ORAI1 or VGCC subunits. Furthermore, I have investigated the 
involvement of intracellular Ca2+ in the activation for TRPC5 in detail.  My results 
point to a central role of TRPC channels in intracellular Ca2+ signalling. 
 
2.1 Store-operated Calcium entry (SOCE) 
 
The cytosolic Ca2+ is a key signalling messenger that regulates a plethora of cellular 
functions from gene transcription to apoptosis. Ca2+ levels can be altered by Ca2+ 
influx from the extracellular space into the cell or by calcium release from intracellular 
stores such as the endoplasmic reticulum (ER). Store depletion is triggered by a 
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relatively small number of second messengers. Besides Ca2+ itself, inositol 1,4,5-
triphosphate (IP3), cyclic ADP ribose and nicotinic acid adenine dinucleotide 
phosphate (NAADP) have been reported to trigger Ca2+ release from intracellular 
stores16. The Ca2+ release from stores is transient in most cases. However, many 
cellular processes and store refilling require sustained elevated intracellular Ca2+ 
levels and this is achieved by Ca2+ entry across the cell membrane. The ~10000-fold 
concentration gradient for Ca2+ across the plasma membrane coupled with a resting 
membrane potential at about -70 mV creates a huge electrochemical driving force for 
Ca2+. Consequently, modest changes in membrane permeability to Ca2+ by opening 
Ca2+ permeable ion channels result in a large Ca2+ influx. A wide variety of Ca2+-
selective ion channels are responsible for this Ca2+ influx. In excitable cells, such as 
neurons and muscle cells, voltage-gated Ca2+ channels (VGCC) represent the major 
entry pathway for Ca2+. In contrast, in non-excitable cells, store replenishment is 
carried out by store-operated Ca2+ entry (SOCE) channels. By definition store-
operated channels activate in response to store depletion even when cytosolic Ca2+ 
levels are buffered to low levels17. Replenishment of the primary cellular Ca2+ store, 
the ER, is an essential process to maintain the functional integrity of this 
compartment. Therefore, after store depletion, store-operated channels are activated 
and Ca2+ influx occurs refilling the stores. The maintenance of the ER Ca2+ levels is 
important for proper cellular functioning and it has been implicated in diseases such 
as severe combined immunodeficiency18, acute pancreatitis19 and Alzheimer`s 
disease20 when SOCE is aberrant. The best characterized type of SOCE is the so 
called Ca2+ release-activated Ca2+ current (ICRAC) initially reported in mast cells5. 
 
2.1.1 Calcium release-activated calcium (CRAC) currents 
 
Over the past 15 years, CRAC currents have been extensively studied in different cell 
types without knowledge of the molecular components. In mast cells, these tiny, 
highly Ca2+-selective currents are activated when ER Ca2+ levels drop independent of 
whether Ca2+ stores are actively depleted via intracellular infusion of IP3 or 
extracellular application of ionomycin or whether Ca2+ store depletion occurs 
passively in response to intracellular perfusion with ethylene glycol bis-N,N,N´,N´-
tetraacetic acid (EGTA) or 1,2-bis(2-aminophenoxy)ethane- N,N,N´,N´-tetraacetic 
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acid (BAPTA)21. As already mentioned, ICRAC was measured in several cell types 
including mast cells, Jurkat leukemic T cells22 and rat basophilic leukaemia cells 
(RBL)23 showing specific biophysical and pharmacological characteristics. CRAC 
currents reveal a single-channel conductance of around ~15 femtosiemens (fS). In 
whole-cell patch clamp experiments, ICRAC displays an inward rectifying I-V-
characteristic with a reversal potential of approximately +50 mV and an amplitude 
highly dependent on the extracellular Ca2+ concentration. CRAC currents activate in 
immediate response (4 – 14 s) to store-depleting reagents such as IP3, thapsigargin 
(TG) or ionomycin whereas current development is delayed when stores are 
passively depleted by intracellular perfusion of EGTA or BAPTA. Notably, CRAC 
currents show a Ca2+-dependent current decay of 30 – 64 % depending on the 
intracellular Ca2+ buffer. ICRAC is inhibited by 2-aminoethoxydiphenyl borate (2-APB) 
and  trivalente cations, La3+ and Gd3+, potently block CRAC currents too21, 24, 25. 
Additionally, a CRAC current hallmark characteristic for CRAC currents is the 
permeability for monovalente cations. Similar to VGCC, Na+ inward currents are only 
conducted in a divalent-free extracellular environment resulting in a strong inwardly-
rectifying current and a modest shift in reversal potential to less positive potentials21 
when compared to ICRAC carried by Ca2+ ions. These CRAC characteristics were used 
to identify CRAC currents in several cell types and to elucidate the molecular 
components in the past 15 years. 
 
2.1.2 Stromal-interaction molecule (STIM) 1 
 
In 2005, Roos et al.26 found an essential component for CRAC currents. The formerly 
described stromal-interaction molecule 1 (STIM1)27 was discovered to maintain a 
required and conserved role in SOCE. Using an RNA interference (RNAi)-based 
screen, 170 genes were tested for involvement in CRAC currents. Drosophila S2 
cells incubated with double stranded RNA (dsRNA) corresponding to a 500 bp 
fragment of CG9126 (Drosophila Stim) demonstrated a clearly reduced (>90 %) 
thapsigargin-induced Ca2+ entry. Additionally, the level of STIM mRNA was reduced 
by >50 % compared to the controls.  
Drosophila STIM protein has two mammalian homologs named STIM1 and STIM2 
which also control CRAC channel activation26, 28-30. STIM1, a 1-transmembrane-
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spanning protein, is localized in the ER membrane functions as a Ca2+ sensor with its 
carboxy-terminus-located EF hand motif reaching into the ER lumen. Interestingly, 
store depletion causes STIM1 to redistribute from a diffuse ER localization into so-
called punctae that are localize in the cell periphery without insertion into the plasma 
membrane. This translocation occurs several seconds before CRAC channels open 
indicating that it is an essential step in CRAC current activation31 (Fig. 1).  
 
 
 
Figure 1: Illustration of CRAC current activation via Ca2+ store (endoplasmatic reticulum; ER) 
depletion by inositol–1, 4, 5–triphosphate (IP3). IP3 binds to the IP3 receptor (IP3R) localized in 
the ER membrane. Ca2+ is released from the ER and STIM1 redistributes into punctae close to 
the plasma membrane activating the CRAC currents (ICRAC) through ORAI. In this process, the 
cytosolic STIM1 C-terminus associates with ORAI C-terminus.  
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2.1.3 The ORAI (CRACM) protein family  
 
In early 2006, three groups individually reported a novel protein designated as ORAI1 
or CRACM1 that represents another essential component for store-operated Ca2+ 
entry. An RNAi screen confirmed that Drosophila olf186-F is an important regulator of 
Ca2+ entry and it was hypothesized that ORAI1 by itself forms the responsible CRAC 
channel, a subunit of the channel or at least a component of the CRAC signalling 
pathway 8, 9, 32. Additionally, T cells derived from two SCID (severe combined 
immuno-deficiency) patients were studied showing decreased Ca2+ entry due to a 
missense mutation in exon 1 of human ORAI1.  
A single cytosine to thymin (C -> T)  nucleotide substitution in position 271 of the 
coding sequence of ORAI1 leads to an arginine to tryptophan mutation at position 91 
(R91W) of the amino acid sequence and disrupts the Ca2+ signal for NFAT 
translocation8.  
ORAI proteins are located in the plasma membrane and reveal four transmembrane 
segments in hydropathy plots with the N- and C-terminus facing the cytosol9, 32. 
Moreover, it was suggested that ORAI proteins form the CRAC channel pore 
because a change in the ion selectivity profile was observed due to the replacement 
of conserved charged amino acid residues in position 106 and 190 with uncharged 
amino acids33. Nevertheless, overexpression of ORAI family members (human 
ORAI1, ORAI2 or ORAI3) alone did not alter endogenous CRAC currents in several 
cell types9 but Jurkat cells injected with ORAI1 or ORAI2 siRNA show suppression of 
SOCE9. In addition, the overexpression of human ORAI1 in T cells derived from 
SCID patients reconstituted Ca2+ entry in response to thapsigargin8. 
A breakthrough observation simplified the following characterization of ORAI 
proteins. Cells overexpressing STIM1 plus ORAI1 showed a clearly detectable CRAC 
current developing in immediate response to intracellular IP3 perfusion11. These 
currents had all the CRAC current hallmark features such as Ca2+ selectivity, 
monovalente conductance upon removing all divalent ions in the extracellular 
solution, and an inhibition by 2-APB11. In combination with STIM1, the human ORAI1 
homologs ORAI2 (CRACM2) and ORAI3 (CRACM3) showed ICRAC potentiation as 
well34. All three ORAI variants exhibit distinct properties in terms of selectivity and 
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pharmacological effects in response to 2-APB and a potential heteromerization 
among ORAI proteins was proposed to provide flexible Ca2+ signalling34. 
 
Related project 
 
As previously mentioned, human STIM1 and human ORAI proteins appear to be the 
molecular components for the store-operated CRAC current. In my study, I focused 
on the functional properties of murine ORAI proteins. The genomic organization of 
the ORAI genes was described by U. Wissenbach from our group35.  
The single copy ORAI1 and ORAI3 genes are localized on the murine chromosomes 
5G1 and 7F2 – 7F3, respectively. Additionally, two gene loci exist for ORAI2, one on 
chromosome 5G2 and a second one on chromosome 16C1. Interestingly, locus 5G2 
is composed of 5 predicted exons which give rise to the splice variants ORAI2Long 
(ORAI2L) and ORAI2Short (ORAI2S) (Fig. 2).  
Alternative splicing involves the exons 2 and 3 and since the start methionine for 
ORAI2L is located in exon 3, the ORAI2S N-terminus is truncated by 14 amino acids 
(Fig. 2). The expression of orai2 on chromosome 16 might lead to a single amino 
acid substitution at position 130 (N130Y; hereafter referred to as ORAI2S (N130Y)) 
whereas ORAI2 proteins are believed to be transcripted exclusively from 
chromosome 535, 36.  
 
In our group, we further investigated the expression of ORAI and STIM proteins in 
murine tissues and cell lines that were used for overexpression experiments. Detailed 
information about the expression pattern is reported in Gross et al., 2007 and 
Wissenbach et al., 200735, 36 in addition to the cloning of murine ORAI proteins and 
STIM1. U. Wissenbach cloned murine STIM1 and murine ORAI1, ORAI2L and 
ORAI2S and additionally murine ORAI2S (N130Y) into expression vector plasmids 
(see Materials and Methods) for investigation in transiently transfected HEK 293 and 
RBL 2H3 cells which provide different genomic backgrounds in endogenous ORAI 
and STIM expression, perfectly suited for the analysis of recombinant CRAC 
channels. 
 
The aim of this study is to determine the functional properties of murine ORAI1, 
ORAI2L and ORAI2S. In co-expression experiments with STIM1, I recorded clearly 
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detectable currents showing CRAC current hallmarks and, furthermore, functional 
interactions between ORAI1 and ORAI2 variants were detectable. Here it is shown 
that the N-terminus of ORAI plays a crucial role in channel activity as it is 
impressively shown in the non-functional ORAI Scid variants.  
Since L-type Ca2+ channel Gamma subunits show similar structural properties to 
ORAI proteins, I further investigated whether STIM1 and GAMMA1 (G1) or GAMMA2 
(G2) reconstitute CRAC currents or whether G1 or G2 interfere with endogenous 
CRAC current development. Finally, I examined CRAC currents in cortical neurons, a 
cell type showing STIM1 and ORAI expression.  
 
 
 
Figure 2: Two different orai2 loci have been identified in the mouse genome. The locus on 
chromosome 5 (chr 5) consists of 5 exons (1 – 5). Transcripts 1, 2 and 3 (transcr 1 – 3) are 
generated by alternative splicing. Start methionines (+1) and stop codons (stop) are shown. 
The N-termini of the encoded amino acid sequences are given below each transcript. 
Transcript 1 encodes a protein (ORAI2L) that is 14 amino acids longer than the protein ORAI2S 
encoded by transcript 2 and 3. The orai2 locus on chromosome 16 contains 3 intron-less exons 
(1*, 4*, 5*) that are highly homologous to exons 1, 4 and 5Modified from U. Wissenbach et al.36. 
 
2.2 TRP ion channels 
 
The mammalian TRP (transient receptor potential) ion channel superfamily consists 
of 28 members divided into six subfamilies named TRPC (canonical), TRPV 
(vaniloid), TRPM (melastatine), TRPA (ankyrin), TRPML (mucolipid) and TRPP 
(polycystins)37. Within a subfamily, sequence homology approaches up to more than  
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90 %, but the corresponding similarity is hard to detect among members of different 
subfamilies. TRP proteins play critical roles in processes ranging from sensory 
physiology to vasorelaxation and male fertility. Originally, the TRP protein was 
identified as a Drosophila gene product required for visual transduction38. The name 
derived from the phenomenon that flies carrying a mutation in the trp locus showed 
rather a transient than a sustained response to light39. Although the crystal structures 
for TRP proteins are not available yet, it is believed that all TRP proteins comprise 6 
transmembrane segments (TM 1 - 6) with a pore forming region between TM 5 and 
TM 6 (Fig. 3). As for voltage-gated K+ channels, it is assumed that TRP channel 
proteins form homo- and heterotetrameric ion channels40. TRP proteins are located in 
the plasma membrane and function as cation permeable ion channels activated by a 
diverse variety of stimuli37, 41. To mention a few, TRPV1 for instance appears to be 
activated by vanilloid compounds such as the active ingredient in hot chilli peppers 
(capsaicin) and anandamide as well as by temperatures exceeding 42°C42. In 
contrast, TRPM8 is activated by temperatures below 26°C and cooling agents such 
as menthol and icilin43. Furthermore, TRP channel modulation results from 
phosphorylation/dephosphorylation or other cellular signalling mechanisms such as 
regulation by  Ca2+/calmodulin41. Genetic approaches in worms, flies and mice 
demonstrate a role for many TRP proteins in sensory processes like 
thermosensation44 and osmosensation45, taste46 and mechanosensation47, just to 
mention a few. Additionally, mutations in TRPs have been linked to human diseases 
such as Mucolipidosis type IV or polycystic kidney disease. Down- and upregulation 
in cancer tissue48, 49 is reported for some TRP proteins as well. Apart from this 
plethora of physiological functions, many TRP studies were designed around the 
SOCE hypothesis suggesting TRP channels as a critical component for Ca2+ entry. 
TRP proteins were reported to contribute to changes in intracellular Ca2+ levels by 
providing a Ca2+ entry pathway, by modulating the driving force for the Ca2+ entry or 
providing intracellular pathways for Ca2+ release from cellular organelles50.  Anyhow, 
so far no mammalian TRP has fulfilled all the criteria set forth for SOCE.       
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Figure 3: (A) A model TRP protein containing six transmembrane domains (TM 1 – 6) with a 
pore loop (pore region) between TM 5 and TM 6 and the TRP domain located at the C-terminus 
(B) Four TRP proteins are assumed to form homo- or hetero-oligomeric channels. Modified 
from Montell, Birnbaumer and Flockerzi, 200237. 
 
2.2.1 Transient receptor potential channel 5 (TRPC5) 
 
TRPC5 is a member of the TRPC subfamily and is closely related to TRPC4 (64 % 
homology) and was first cloned from rabbit and mouse brain by Philipp et al., 199813. 
The protein is reported to be expressed in neurons, sperm head, smooth muscle cells 
and mast cells51-54. In homo-multimeric or hetero-multimeric assembly with TRPC1, 
the activation occurs via G-protein (Gq/11-type)-coupled receptor stimulation. 
Accordingly, intracellular GTP-γ-S (a stable analogue of guanosine triphosphate) is 
sufficient to stimulate TRPC555. Channel activation by muscarinic agonists or 
epidermal growth factor (EGF) is surpressed by the phospholipase C (PLC) inhibitor 
U73122 suggesting that PLC activity plays an elementary role in channel activation56. 
IP3 or its receptor are discussed to be involved in TRPC5 activation whereas 
diacylglycerol (DAG) appears to inhibit TRPC5 rather than activate56. Moreover, a 
striking feature of TRPC5 is its strong activation by extracellular lanthanides such as 
lanthanum or gadolinium57. All the other TRP channels show inhibition in the 
presence of extracellular lanthanides.  
The importance of intracellular Ca2+ levels is widely discussed among several 
laboratories. It has been shown that TRPC5 is activated in response to ionomycin58, 
a store-depleting ionophore, as well as in response to thapsigargin (TG)13. 
Furthermore, the buffering of intracellular Ca2+ levels to sub-physiological 
concentrations suppresses the activation of TRPC5 by other stimuli59.  
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Channel activation and also rapid translocation from intracellular vesicles to the 
plasma membrane occurs in response to epidermal growth factor (EGF). These 
vesicles are located in close proximity to the plasma membrane and TRPC5 
channels relocate to the plasma membrane providing a greater surface expression of 
the channel protein60. An important binding partner of TRPC5 is the Ca2+-binding 
protein calmodulin (CaM) which plays a role in mediating Ca2+ signals. Two binding 
CaM domains were identified (Fig. 4): A so called CIRB site (CaM-IP3 receptor 
binding) and a second binding site named CBII (CaM binding site II)61, 62 located at 
the C-terminus. CaM binding site mutants differ in current activation by receptor 
stimulation. Cells overexpressing TRPC5ΔCBII mutants show a reduced histamine-
induced Ca2+ entry in comparison to WT TRPC5 transfected HEK 293 cells. TRPC5 
with CIRB site mutations did not show any current development in response to 
histamine perfusion62.               
TRPC5 inhibition is mediated by 2-aminoethoxydiphenyl borate (2-APB) occurring 
exclusively at the external face of the channel63. Moreover, chlorpromazine64, 
calmidazolium and SKF-9636565 block receptor-activated TRPC5 currents and 
hallmark activators lanthanum and gadolinium inhibit current development in high 
extracellular concentrations (>100 µM)57. 
 
Related Project 
 
TRPC5 ion channels appear to be activated by a multiplicity of signals and, thus, 
there has been a lively discussion about whether TRPC5 is store-operated or 
activated by PLC signalling cascade. Recent reports define SOCE channels as ion 
channels activated by STIM1 and they show that STIM1 is obligatory for TRPC5 
channel activation by agonists66. Another TRPC5 channel modulator is diacylglycerol 
(DAG) and protein kinase C (PKC) activation leads to a current fade out over time59. 
As seen in Fig. 4, the TRPC5 activation pathway depends on several crucial steps, 
whereas the direct activator has not been identified so far. 
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Figure 4: Schematic summary of TRPC5 activation by muscarinic agonists (CCH: carbachol; 
MR: muscarinic receptor). GTP bound G-protein (Gα, β and γ) activates the phospholipase C 
(PLC) resulting in the cleaving of phosphatidylinositol bisphosphate (PIP2) into inositol 
triphosphate (IP3) and diacylglycerol (DAG). IP3 binds to the endoplasmatic reticulum (ER) 
membrane located IP3 receptor (IP3R) resulting in store depletion. DAG remains on the cell 
membrane activating protein kinase C (PKC; not shown here). Two calmodulin binding sites 
are located at the C-terminus of TRPC5 (CIRB and CBII). The ultimate step in activation of 
TRPC5 channels is not known. 
 
 
The aim of this study is to determine the final mediator for TRPC5 activation. TRPC5 
channels were originally described as SOCE channels and initial investigations have 
left room for interpretations to functional interactions between TRPC5, STIM1 and 
ORAI1. Here, it is shown that the least common denominator for TRPC5 activation is 
the rise in the intracellular Ca2+ concentration ([Ca2+]i) leading to a dose-dependent 
Ca2+-activation mechanism. Furthermore, CRAC currents mediated by STIM1/ORAI1 
and Ca2+ influx through L-type Ca2+ channels act as a physiological Ca2+ donor. 
Thus, activation of these `donor´ channels have resulted in a rise of local Ca2+ levels 
inducing to TRPC5 current development. These observations make a good case for 
novel regulatory mechanisms in Ca2+ signalling and a new physiological relevance for 
TRPC5 ion channels.  
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3 Materials and Methods 
 
3.1 Cell culture and transfection  
3.1.1 STIM1 and ORAI experiments 
 
Human embryonic kidney cells (HEK 293) and rat basophilic leukaemia cells 
expressing the human muscarinic receptor M1 (RBL 2H3 referred to as RBL) were 
cultured as previously described67. Plasmids containing the cDNAs of the murine 
STIM1, ORAI1, ORAI2L, ORAI2S, GAMMA1, GAMMA2, TRPC3 and TRPC5 were 
transfected into these cells either individually or in combination using the PolyFect 
transfection reagent (Qiagen, Hilden, Germany). For individual transfections, 3 μg of 
each plasmid was used per cell dish. For co-transfections, the STIM1 plasmid was 
mixed with one of the plasmids containing ORAI1, ORAI2L, ORAI2S, GAMMA1 or 
GAMMA2 at a ratio of 1:2 or a TRPC plasmid was mixed with one of the plasmids 
containing STIM1, ORAI1 or ORAI2S. The total amount of plasmid mix was 3 µg per 
cell dish. For triple co-transfections, plasmids containing STIM1, ORAI1 and either 
ORAI2L, ORAI2S, TRPC3 or TRPC5 were mixed at a ratio of 1:2:1. Accordingly, the 
total amount of plasmid mix was 4 µg per cell dish. The bicistronic expression vector 
pdi contained the cDNA of the enhanced green fluorescence protein (GFP) as 
expression marker. Patch clamp experiments were performed on GFP expressing 
cells 2-3 days after transfection. 
 
3.1.2 TRPC5 experiments 
 
HEK 293 cells were cultured as described. TRPC5 plus M2R (muscarinic receptor 2) 
stably transfected HEK 29368 (a gift from Mike Zhu, Ohio, USA) hereafter referred to 
as TRPC5-stably transfected HEK 293 cells were cultured in DMEM 41966 medium 
(Gibco, Karlsruhe, Germany) containing 10 % heat-inactivated fetal calf serum, 
penicillin-streptomycin (100 µg/ml; Gibco), hygromycin B (100 µg/ml; PAA) and G418 
(400 µg/ml; Gibco). Individual transfections of STIM1, ORAI1, ORAI2S, ORAI1 Scid, 
ORAI2S Scid, TRPC3, TRPC5, TRPC5 CIRB mutant 1 in pIRESneo (J130562), 
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TRPC5 DelCBII in pIRESneo (J130762), were performed using the AMAXA 
Nucleofector® electroporation system (AMAXA biosystems, Cologne, Germany) 
according to the general protocol for nucleofection of adherent cell lines provided by 
AMAXA. J1305 and J1307 plasmids were kindly provided by Mike Zhu62. For co-
transfections, plasmids containing STIM1 were mixed with ORAI1 and ORAI1 Scid in 
the ratio 1:1. For triple transfections, the alpha-subunit and the beta-subunit of L-type 
Ca2+-containing expression vectors were mixed with a GFP-containing pCAGGS 
vector plasmid in the ratio 2:2:1. The total amount of plasmid per transfection was 5 
µg. Experiments were performed on GFP expressing cells 1 - 3 days after 
transfection or in non-transfected TRPC5 stable cells or HEK 293 control cells 1 - 2 
days after plating. 
 
If not mentioned otherwise, all cDNAs were subcloned downstream of the chicken 
actin promotor into the pCAGGSM2 vector containing an IRES GFP site as described 
elsewhere36, 69. 
 
3.1.3 Isolation of cortical neurons 
 
Single neurons for PCR analysis were prepared similar as described in Neumann et 
al., 199570. Cells were maintained in culture for 1 – 2 days before use. 
 
3.2 Treatment with cytochalasin D, U73122 and EGF  
3.2.1 The mycotoxin cytochalsin D 
 
Cytochalasin D, Zygosporium mansonii (Calbiochem) is a fungal metabolite that has 
the ability to bind actin filaments and block actin polymerization and, thus, the cellular 
morphology undergoes changes and cellular processes such as cell division and 
vesicular translocation are inhibited71-73. In the present experiments, cells were 
incubated in medium containing 10 µM cytochalasin D for 10 min at 37°C. Afterwards 
cells were washed with external solution used in the patch clamp experiments. The 
stock solution contained 1 mM cytochalsin D which was prepared using  dimethyl 
sulfoxide (DMSO). 
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 3.2.2 The PLC inhibitor U73122 
 
U73122 (Calbiochem) inhibits agonist-induced phospholipase C (PLC) activation74. In 
indicated experiments, cells were incubated in 2 µM U73122 containing culture 
medium for 5 min at 37°C and washed with external solution prior to patch clamp 
recordings. Stock solution contained 2 mM U73122 in DMSO.  
 
3.2.3 Epidermal growth factor (EGF) 
 
Epidermal growth factor (EGF) from mouse submaxillary glands (Sigma-Aldrich) is a 
growth factor that plays an important role in the regulation of cell growth, proliferation 
and differentiation. Further roles include neuromodulation of the central nervous 
system75 and also modulation of TRPC ion channels60, 76. In the present experiments, 
cells were incubated for 4 min at 37°C in external solution containing 100 ng/ml EGF 
and 0.5 % bovine serum albumin (BSA; Sigma-Aldrich). Cells were washed with 
basic external solution before experiments. The stock solution contained 10 µg/ml 
EGF diluted in H2O. 
 
3.3 Scid mutations in murine ORAI1 and murine ORAI2S 
proteins 
 
Based on mORAI1 and mORAI2S containing pcDNA3 vector plasmids (Invitrogen) 
cloned by U. Wissenbach36, murine ORAI1 Scid and murine ORAI2S Scid mutations 
were generated. The non-functional human ORAI1 Scid mutation was described as 
an C to T transition at position 271 of the coding sequence of ORAI1 resulting in an 
arginine to tryptophan substitution at position 91 in the ORAI1 amino acid sequence 
(R91W)8. According to Feske et al.8, I designed the following primer pairs for ORAI1 
and ORAI2S to introduce a single nucleotide exchange (C to T) at position 277 of the 
coding sequence of mORAI1 and at position 235 of mORAI2, respectively resulting in 
R91W in murine ORAI1 and R78W in murine ORAI2: 
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mOrai1:  5´-GCTCAAAGCTTCCAGCTGGACCTCGGC-3´ (SG1)  
              5´-GCCGAGGTCCAGCTGGAAGCTTTGAGG-3´ (SG2)  
mOrai2S:  5´-GCCTCCAGCTGGACCTCAGCCCTCC-3´ (SG3)     
                 5´-GGAGGGCTGAGGTCCAGCTGGAGGC-3´ (SG4)   
(Operon, Cologne, Germany) 
 
For mutagenesis, the Quick Change® Site-Directed Mutagenesis Kit (Stratagene, 
California, USA) was used according to the provided protocol and mutated plasmids 
were transformed into competent XL1-blue Escherichia coli bacteria (Stratagene). 
Single colonies were picked and incubated in 50 µg/ml ampicillin containing LB-
medium (lysogeny broth). DNA isolation was performed by using the QIAprep Spin-
Miniprep Kit (Qiagen, Hilden, Germany) according to the provided protocol and the 
ABI Prism® sequencer 310 Genetic Analyzer (Applied Biosystems, California, USA) 
was used for DNA sequencing. This technique is based on the dye-terminator 
sequencing principle, a common alternative among the chain-termination methods of 
DNA sequencing. Chain termination sequencing was developed by Sanger and the 
key principle is the use of dideoxynucleotides triphosphates (ddNTPs) as DNA chain 
terminators. I used the Big Dye® terminator v.1.1 cycle sequencing kit providing a 
fluorescence-labelled ddNTPs containing dNTP mix as follows: 
 
0.5 µg DNA template  
1.5 µl Big Dye terminator v1.1 ready reaction mix 
1 µl primer (10 pmol/µl) 
ad 12 µl H20 deionized. 
 
PCR temperature cycle: 
 
After PCR, 12 µl probes were purified by sepharose spinning and denatured by 
adding 8 µl HiDye® (Applied Biosystems). Purified and denatured probes were 
sequenced using Prism® sequencer 310 Genetic Analyzer. Provided data collection 
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software and sequencing analysis software was used to record and analyse the 
resulting sequences. 
 
Table 1: (A) Primer pairs to confirm the nucleotide exchange C to T in mORAI1 and 
mORAI2S containing pcDNA3 vector plasmids after mutagenesis. (B) Primer pair to check 
directed insertion into pCAGGSM2/IRES GFP vector plasmid after ligation. All primers were 
synthesized by Operon, Cologne, Germany. 
 
 Sequencing Primer name Sequence 5´ to 3´ 
ORAI1/2S Scid pcDNA3 pRCforUW CTAGAGAACCCACTGCTTACA 
ORAI2S Scid pcDNA3 UW615 GCCAGCTCGATGTACGG 
pCAGGSforUW AACBTGCTGGTTGTTGTGC B ORAI1/2S Scid 
pCAGGSM2/IRES GFP pCAGGSrevUW CATATAGACAAACGCACACC
 
Confirmed ORAI1 Scid and ORAI2S Scid-containing pcDNA3 plasmids were treated 
as follows: 
 
ORAI1 Scid pcDNA3 (Fig. 5) 
Plasmid vector was cut by XhoI. 
DNA fragments were separated by gel electrophoresis on 0.8 % GTQ-agarose (Roth, 
Karlsruhe, Germany) gel. 
Expected DNA band for the mORAI1 Scid fragment (915 bp) was electro-eluated, 
ammonium acetate precipitated and dissolved in 22.75 µl deionized H20. 
Blunting (= sticky ends due to XhoI cut were filled up with dNTPs to blunt ends): 
  
22.75 µl DNA template 
 1.25 µl dNTP mix (1.25 mM; New England BioLabs) 
 2 µl T4-polynucleotide kinase (New England BioLabs) 
 1 µl T4 DNA-polymerase (New England BioLabs) 
 3 µl ligase buffer (New England BioLabs)  
 (30 min at 37°C, 10 min at 75°C (enzyme inactivation)) 
Ammonium acetate precipitation  
DNA template was dissolved in 20 µl deionized H20 
 
Over night ligation at 16°C of the blunted ORAI1 Scid DNA template into EcoRV cut 
pCAGGSM2/IRES GFP vector plasmid: 
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 1 µl ligase (New England BioLabs) 
 2 µl ligase buffer (New England BioLabs) 
 1 µl pCAGGSM2/IRES GFP, EcoRV, AA (50 ng/µl) 
 16 µl blunted ORAI1 Scid insert 
 
ORAI2S Scid pcDNA3 (Fig. 5) 
ORAI2S Scid fragment was amplified from the OAI2S Scid-containing pcDNA3 
vector: 
2.5 µl UW 605 (10 pmol/µl; Operon:  
5´-[Phos]CCGCCGCCACCATGAGTGCAGAGCTCAATGTGC-3´) 
 2.5 µl UW 606 (10 pmol/µl; Operon: 
  5´-[Phos]TCACACCACCTGCAGGCTC-3´) 
1.0 µl dNTP mix (1.25 mM; New England BioLabs) 
10 µl HF-buffer (Finnzymes) 
1 µl Phusion™ High-fidelity DNA polymerase (Finnzymes) 
ad 50 µl H2O deionized  
 
PCR temperature cycle:  
 
DNA fragments were separated by gel electrophoresis on 0.8 % GTQ-agarose gel 
(Roth, Karlsruhe, Germany). 
Expected DNA band for the mORAI2S Scid fragment (750 bp) was electro-eluated, 
ammonium acetate precipitated and dissolved in 22.75 µl deionized H20. 
Over night ligation at 16°C of the ORAI2S Scid DNA template into EcoRV cut 
pCAGGSM2/IRES GFP vector plasmid: 
  
 
1 µl ligase (New England BioLabs) 
 2 µl ligase buffer (New England BioLabs) 
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 1 µl pCAGGSM2/IRES GFP, EcoRV, AA (50 ng/µl) 
 5 µl blunted ORAI1 Scid insert 
 ad 20 µl H2O deionized 
 
ORAI1 Scid and ORAI2S Scid containing pCAGGSM2/IRES GFP vector plasmids 
were cut with EcoRI to confirm whether ligation was successful or whether the DNA 
insert was not integrated. In addition, the vector plasmids were sequenced using 
primer pair pCAGGSforUW and pCAGGSrevUW (Table 1) to confirm site-directed 
insertion. 
 
Final plasmids:  
mORAI1_Scid pCAGGSM2/IRES GFP Kl. 10 (Nov. 12, 2007)  
mORAI2short_Scid pCAGGSM2/IRES GFP Kl. 3 (Nov. 22, 2007)  
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Figure 5: Schematic overview about the generation of mORAI Scid mutant pCAGGSM2/IRES 
GFP plasmid vectors based on mORAI1 and mORAI2S-containing pcDNA3 plasmid vectors. C 
to T mutation (black dot) was made using the Quick Change site-directed mutagenesis kit. XhoI 
cut and blunting (mORAI1 Scid) or PCR amplification (mORAI2S) was prerequisite to ligating 
the mutated DNA templates to pCAGGSM2/IRES GFP plasmid vectors. 
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3.4 Patch Clamp techniques 
 
The patch clamp technique allows the recording of ionic currents flowing across 
biological membranes through pore-forming ion channels.  Single as well as multiple 
ion channel currents can be studied using the patch clamp technique77. Patch clamp 
recordings are performed with glass micropipettes that have a tip diameter  
of 1 – 5 µM. Usually, the pipettes are fire-polished in a microforge to produce a 
smooth surface tip improving the establishment of a so-called “gigaseal” with the cell 
membrane. Initially the pipette is moved towards the cell. To protect the tip of the 
pipette from contaminations, a positive pressure is usually applied to the pipette 
interior. When the pipette tip carefully touches the cell membrane, gentle suction is 
applied to establish a very tight contact or seal called “gigaseal”. The term gigaseal 
describes the fact that glass pipette and cell membrane establish a very tight 
conjunction hindering a free ion flow between the pipette solution and the external 
solution and, thus, displaying resistance >1 GΩ. To obtain the so-called “tight-seal 
whole-cell” configuration of the patch clamp technique, a short negative pressure is 
applied to break the membrane patch underneath the pipette. In this configuration the 
membrane currents flowing through the whole membrane of the cell are recorded. 
With patch clamping, only one micropipette is used for both voltage clamping and 
current measurement in contrast to traditional voltage clamping. This means that the 
membrane potential is held constant, while the current flowing between intracellular 
and extracellular environment through ion channels is measured. A basic electrical 
circuitry for patch clamp measurements is shown in Fig. 6.  
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Table 2: Internal (A) and external (B) patch clamp solutions. Additional reagents were 
added to patch clamp solutions as described in the results.   
 
A 
 Basic 1 Calcium solutions Basic 2  
Substance Final conc. (mM) Final conc. (mM) Final conc. (mM) Provider 
CsCl 120 120  Serva GmbH
NaCl 10 10 8 Merck KGaA
MgCl2 3 3 3 Merck KGaA
EGTA 10 10  Sigma-Aldrich Inc.
HEPES 10 10 10 Sigma-Aldrich Inc.
Glutamic Acid   120 Sigma-Aldrich Inc.
(K+)-BAPTA   10 Sigma-Aldrich Inc.
CsOH   pH titration Acros
CaCl2  0.01 - 10 µM free Ca2+   
     
pH 7.2 - 7.3 7.2 - 7.3 7.2 - 7.3  
 
Free Ca2+ concentration was calculated in Webmaxc Standard; 
http://www.stanford.edu/~cpatton/webmaxcS.htm 
 
    Additional reagents  
Substance Final conc. Provider 
IP3 20 µM Calbiochem
4-BrA23187 200 nM Teflabs
Ionomycin 5 µM Calbiochem
 
B  
 Basic NCaF DVF  
Substance Final conc. (mM) Final conc. (mM) Final conc. (mM) Provider 
NaCl 120 120 120 Merck KGaA
CsCl 10 10 10 Serva GmbH
MgCl2 2 2  Merck KGaA
CaCl2 5   Merck KGaA
HEPES 10 10 10 Sigma-Aldrich Inc.
Glucose 10 10 10 Merck KGaA
EGTA   1 Sigma-Aldrich Inc.
HEDTA   1 Sigma-Aldrich Inc.
     
pH 7.2 - 7.3 7.2 - 7.3 7.2 - 7.3  
 
   Additional reagents  
Substance Final conc. Provider 
Carbachol 200 µM Sigma-Aldrich Inc.
U73122 2 µM Calbiochem
Cytochalasin D 10 µM Calbiochem
EGF 100 ng/ml Sigma-Aldrich Inc.
BSA 0.50% Sigma-Aldrich Inc.
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Figure 6: Conceptual diagram of the Patch clamp setup. The feedback resistor (RF) and the 
operational amplifier (OPA) are the key components of this system. The amplifier induces 
according to a reference (Vref) of an appropriate current pulse to clamp the membrane 
potential at desired levels (modified from Gross, 200578).  
 
In this study, patch clamp recordings were performed in the tight-seal whole-cell 
patch configuration to record CRAC currents, Ca2+ currents through L-type Ca2+ 
channels, non-selective currents through TRPC5 channels and Na+ currents in 
cortical neurons. The advantage of whole-cell recordings is that the intracellular 
medium is defined by the pipette solution and activating reagents can be applied to 
the intracellular environment. 
 
Patch pipettes (borosilicate glass, Biomedical Instruments) were made in a two-step 
puller (H. Ochotzki, Homburg). The pipettes were filled with a saline solution 
hereafter referred to as the internal or pipette solution (Table 2, A). Cells are perfused 
with a solution of defined composition hereafter referred to as the external or bath 
solution (Table 2, B). For recording the time course of developing currents, voltage 
ramps from +80 mV to -100 mV (duration 50 ms; STIM1 / ORAI experiments) or from 
-100 mV to +100 mV (duration 50 ms; TRPC5 experiments) were applied every 2 s 
for at least 100 s. In the STIM1 / ORAI experiments in which the external solution 
was exchanged, voltage ramps were applied every 0.5 s. The holding potential was 0 
mV and sampling rate was 20 kHz (STIM1 / ORAI) and 10 kHz (TRPC5). In STIM1 / 
ORAI1 experiments inward current development was monitored at -90 mV for each 
individual voltage clamp ramp whereas potentials of -80 mV and +80 mV were used 
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to monitor inward and outward currents, respectively, in TRPC5 experiments. Current 
densities were calculated as the current amplitude a) subtracted by the individual 
background current in STIM1 / ORAI experiments or b) non-subtracted amplitude in 
TRPC5 experiments and divided by the appropriate initial Cslow. Capacitive currents 
were determined and corrected in advance of each voltage ramp. Step protocols 
were delivered from -100 mV to +100 mV in 10 mV steps from the holding potential at 
0 mV or at 60 mV (L-type channel experiments). TRPC5 / L-type channel activation 
was recorded by applying a two step voltage protocol every 2 s. From holding 
potential at -60 mV (50 ms), voltage step to 0 mV (100 ms) and voltage step to +80 
mV (50 ms). Local external solution perfusion was applied with a pressure-controlled 
8-valve local perfusion system (ALA Scientific Instruments, New York, USA; PR-10, 
ALA-VM8; 4 channel perfusion pencilTM, Micromanifolds® QMM-4 and custom made 
pipette tips: dead volume ~ 150 µl). Pulse v8.80 (HEKA) software was used to control 
the EPC-9 patch clamp amplifier (HEKA, Lambrecht, Germany) and to record and 
visualize the currents. PulseFit v8.80 (HEKA), Igor Pro 5.0.1.0 (Wavemetrics Inc.) 
and SigmaPlot 9.01 (SPSS Inc.) were used for analysis.   
 
3.5 Ca2+ imaging   
  
Ca2+ imaging is used to study the calcium status of a tissue or individual cell. It takes 
advantage of Ca2+ indicators that respond to the binding of Ca2+ ions by changing 
their spectral properties79. Single wavelength Ca2+ indicators (Fluo-3) as well as 
ratiometric indicators (Indo-1, Fura-2) are commonly used for Ca2+ imaging. The 
advantage of ratiometric dyes over single wavelength indicators is that possible 
artefacts due to photobleaching and different dye loading are avoided. For instance, 
upon Ca2+-binding, the fluorescence excitation maximum of FURA-2 undergoes a 
blue shift from 363 nm (Ca2+-free) to 335 nm (Ca2+-saturated), while the fluorescence 
emission maximum is relatively unchanged at approximately 510 nm. Therefore, the 
ratio of intensities of the fluorescence emitted by exciting at 340 and 380 nm is 
directly related to the free Ca2+ concentration.  
 
Ca2+ imaging experiments were performed to record the intracellular Ca2+ transients 
due to store depletion in response to thapsigargin or charbachol. The advantage of 
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the system is that the intracellular environment is not changed and further effects due 
to Ca2+ release from the stores are detectable. Moreover, the Ca2+ entry through non-
selective TRP5 channels can be monitored. 
 
In the present study, intracellular Ca2+ transients were measured using FURA-2 in 
individual cells by fluorescence microscopy using the iMIC (TILL photonics, 
Gräfelfing, Germany) and TILLvisION (TILL photonics) software. Cells (HEK 293 and 
TRPC5-stably transfected HEK 293) were grown on poly-L-lysine-coated cover slips 
and incubated with 10 µM FURA-2AM (Molecular Probes) for 40 min at room 
temperature and then washed with basic external solution (HBSS; Table 2). The 
coverslips were placed into a circular open-bottom chamber and mounted onto the 
stage of the iMIC. Intracellular Ca2+ transients in individual cells were monitored at 
room temperature exciting FURA-2 alternately at 340 nm and 380 nm for 10 ms each 
using a Polychrome V (TILL photonics; no excitation filter) and recording the emitted 
fluorescence at 510 nm (Dicroic: DCLP410; Emitter filter: LP470 TILL photonics). All 
reagents were applied by adding the reagent containing basic solution to the cells 
(principle shown in Fig. 7). 
 
Figure 7: Simplified perfusion in Ca2+ and membrane potential imaging experiments. Activating 
reagents were dissolved 2 or 3 times higher in basic solution (basic sol.) and added in to 
appropriate volumes to the cell chamber to obtain the desired final concentrations.  
 
Results are given as the background subtracted ratios of F340/F380 calculated in 
TILLvisION (TILL Photonics) and Sigma Plot 9.01 (SPSS Inc.). Regions containing 
no cells were used as background. Solutions are listed in Table 3. 
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3.6 Membrane potential imaging 
 
Membrane potential is defined as the electrical potential difference (voltage) across 
the plasma membrane of a cell and is determined by the ion channels present in the 
membrane as well as by the ionic gradients across the membrane At rest, the 
membrane potential is kept relatively stable and changes in membrane potential 
provide the basis for a fast communication between cells in a functional environment 
such as neuronal networks. In the case of the standard membrane potential across, 
potassium and sodium concentration gradients are established by the Na-K-ATPase 
(Na+-K+-exchanger). Under stable conditions, cells maintain a resting potential which 
can be calculated for Na+, K+ and Cl- using the Goldman equation (equation (1); also 
referred as Goldman-Hodgkin-Katz equation)80.  
 
                  equation (1)    
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Em = The membrane potential 
T = The temperature in kelvins 
R = The ideal gas constant  
Pion = the permeability for that ion 
F = The Faraday´s constant 
[ion]O = the extracellular concentration of that ion  
[ion]I = the intracellular concentration of that ion 
 
As shown in equation (1), the permeability of the cell membrane (P) for specific ions 
is an important value for establishing the membrane potential and reflects the number 
of open channels, which are selective for a specific ion. If ion channels change their 
open probability in response to specific reagents, a shift in membrane potential will 
be expected. 
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Table 3: External solutions used for Ca2+ and membrane potential imaging.  
 
  Substance final conc. (mM) Provider 
HBSS CaCl2 1.26
 KCl 5.36
 KH2PO4 0.44
  MgSo4 0.81
  NaHCO3 4.16
  NaCl 136.89
  Na2HPO4 0.34
  Glucose 5.5
   
 
Molecular Devices 
  
  
  
        
Ca2+-free NaCl 120 Merck KGaA 
  KCl 4 Merck KGaA 
  MgCl2 2 Merck KGaA 
  Hepes 10 Sigma-Aldrich Inc. 
  Glucose 10 Merck KGaA 
        
high K+ NaCl 93 Merck KGaA 
  KCl 67 Merck KGaA 
  HEPES 10 Sigma-Aldrich Inc. 
  Glucose 5 Merck KGaA 
        
Additional reagents Carbachol 0.13 Sigma-Aldrich Inc. 
  Thapsigargin 0.001 Calbiochem 
 
A fluorescence-based assay for detecting changes in voltage across the plasma 
membrane was used in the present experiments. The advantage of such an 
approach is that the internal milieu of the cell is not modified. In the present study, the 
activation of non-selective TRPC5 channels resulted in a membrane potential shift, 
as the permeability for Na+ and Cs+ was changed. 
 
The FLIPR® Membrane Potential Assay Kit (Molecular Devices, California, USA) 
consists of the Membrane Potential Assay BLUE hereafter referred to as FLIPR® dye 
and Hanks´BSS (HBSS listed in table 3 with 20 mM HEPES, pH = 7.4 (Kit number: 
R8042). The membrane potential dye solution was prepared by dissolving the 
contents of one bottle FLIPR® dye in HBSS / Hepes to a volume of 10 ml. The 
solution was kept in the dark and was stable at room temperature. Cells (HEK 293 
control cells or TRPC5-stably transfected HEK 293 cells) were grown on poly-L-
lysine-coated cover slips and incubated with FLIPR® dye containing HBSS for 12 min 
at room temperature. Importantly, the FLIPR® dye is not washed out after cell loading 
as it is done with FURA-2AM. Therefore all solutions used during an experiment 
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contain the FLIPR® dye at the same concentration as the loading solution HBSS. 
After incubation, coverslips were placed into a circular open-bottom chamber and 
mounted onto the stage of the iMIC (Experimental setup and software as described 
for Ca2+ imaging). To determine background fluorescence signals, the dye was 
excited at 350 nm for 5 ms. During the recording, cells were excited at 530 nm for 5 
ms and the emitted fluorescence was recorded at 600 nm (Dicroic: 565 DCXR; 
Emitter filter: ET 605/70m AF Analysetechnik, Tübingen, Germany). The changes in 
the FLIPR® dye fluorescence are presented as ΔI/I0 values, whereby positive values 
represent a depolarization of the cell membrane. In the present study, ΔI/I0 values 
below zero that represent hyperpolarization of the cell membrane were not observed. 
The ΔI/I0 values (I = intensity) were obtained as follows: First, the 3rd pulse of the 350 
nm excitation protocol was subtracted from the 10th pulse of the 530 nm excitation 
protocol (I0 = 530p10 – 350p3), which represent the basal fluorescence before 
stimulation. Second, this basal fluorescence was subtracted from the fluorescence 
signals recorded over time (ΔI = 530 – 530p10). Third, the ratio between ΔI and I0 was 
calculated (Microsoft Excel, Microsoft).  
 
3.6.1 Combination of Ca2+ imaging and membrane potential detection 
 
Due to defined differences in fluorescence properties (Fig. 8), FURA-2 signals and 
FLIPR® signals could be recorded simultaneously to achieve a high resolution 
chronology of Ca2+ signals and membrane potential changes. 
 
Cells (HEK 293 and TRPC5-stably transfected HEK 293) were grown on poly-L-
lysine-coated cover slips and incubated with 10 µM FURA-2AM (Molecular Probes) 
for 40 min at room temperature and then washed with basic external Hank´s Buffered 
Salt Solution (HBSS). Afterwards cells were incubated with FLIPR® dye containing 
HBSS for 12 min at room temperature. As mentioned before FLIPR® dye is not 
washed out. To record FURA-2 and FLIPR® signals, a macro was programmed in 
TILL visION to change the corresponding filtersets alternately (Fig. 8, Fig. 9). Data 
analysis and statistical analysis were performed as described for individual Ca2+ 
imaging experiments or membrane potential detection.  
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Figure 8: Excitation and emission fluorescence spectra for Fura-2 (y) and Ca2+-saturated Fura-2 
(x). Arrows indicate excitation wavelength (downward) and emission wavelength (upward) for 
FURA-2 experiments (grey gradient) or FLIPR experiments (black gradient). (A) and (B) show 
the optical properties for FURA-2 filterset: (A) dicroic: DCLP410; (B) emitter: LP470; (C) and (D) 
show FLIPR filterset: (C) dicroic: 565 DCXR; (D) emitter: ET 605/70m.   
 
 
 
Figure 9: Simultaneous recordings of FLIPR and FURA-2 signals. In each cycle, the FLIPR 
signals were measured before FURA-2 signals. First, the FLIPR dye was excited at 530 nm for 5 
ms and the emitted fluorescence was obtained at 600 nm using the FLIPR filterset. Second, the 
FURA-2 filterset was placed in position and FURA-2 was excited at 340 nm for 10 ms and the 
emitted light was obtained at 510 nm and then excited at 380 nm for 10 ms and the emitted 
fluorescence was obtained at 510 nm. Afterwards, the FLIPR filterset was placed in position 
and the cycle was repeated. 
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3.7 Statistical analysis 
 
Statistical analysis was performed using Microsoft Excel 2003 (Microsoft Coorp., 
Washington, USA), Igor Pro 5.0.1.0 (Wavemetrics Inc., Oregon, USA) and SigmaPlot 
9.01 (SPSS Inc., Illinois, USA). Paired or unpaired Student’s t-test analyses were 
performed to determine differences between samples. Statistical data are given as 
mean ± s.e.m, where n is the number of individual experiments in 
electrophysiological recordings or individually recorded cells in fluorescence imaging 
experiments. P < 0.05 (asterisk), P < 0.01 (two asterisk) and P < 0.001 (three 
asterisk) are considered to be significant.    
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4 Results 
 
4.1 Murine ORAI proteins form functional CRAC channels 
 
The molecular components which reconstitute CRAC channels have been enigmatic 
for years until STIM1 and ORAI1 were reported to play a role in ICRAC activation. In 
this thesis, murine ORAI1, ORAI2L, ORAI2S, ORAI2S (N130Y) and STIM1 were 
cloned as described elsewhere36 and used to elucidate the functional properties of 
these proteins.  
First, endogenous ICRAC was recorded in both, HEK 293 and RBL 2H3 cells to define 
a threshold that allows the detection of CRAC currents through recombinant channels 
(Fig. 10, Fig. 11). Each of the cell lines provides a different background of 
endogenous STIM1 and ORAI protein expression36 and endogenous CRAC current 
(Fig. 10, Fig. 11). ICRAC was activated by adding IP3 to the pipette solution under 
buffer of internal Ca2+ with 10 mM EGTA and the currents were measured in the 
presence of 5 mM external Ca2+. In the whole-cell configuration of the patch-clamp 
technique, RBL 2H3 cells showed a clearly detectable and fast developing inward-
rectifying current (Fig. 10 E, F) with an average current density of approximately -2.5 
pA/pF (Fig. 11 B). In HEK 293 cells, only 4 out of 13 cells showed a small inward-
rectifying ICRAC with an average current density of -0.5 pA/pF (Fig. 10 A, B; Fig. 11 A). 
The cell lines vary in endogenous expression of STIM1 and ORAI proteins and thus 
the size of endogenous CRAC currents (Fig. 10, Fig. 11).  
Overexpression of STIM1 resulted in an increase of CRAC currents in RBL 2H3 and 
HEK 293 cells. In RBL 2H3 cells, ICRAC density was doubled by overexpression of the 
CRAC component STIM1 (-4.5 pA/pF vs. 2.5 pA/pF, Fig. 11 B). The inward-rectifying 
current-voltage relationship and activation kinetics exhibit the characteristics of 
endogenous CRAC currents. In STIM1-transfected HEK 293 cells, ICRAC was barely 
detectable. The average current density was slightly increased to -1 pA/pF (Fig. 11 A) 
when compared to endogenous CRAC currents. In conclusion, HEK 293 cells 
represent a cell background, in which ICRAC is hardly detectable even after over-
expression of STIM1. In contrast CRAC currents in RBL 2H3 cells appeared to be 
readily modulated by the overexpression of STIM1. The individual STIM1-dependent 
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current densities served as threshold levels (indicated as dashed line in Fig. 11 A, B) 
for the detection of CRAC currents mediated by recombinant ion channels formed by 
ORAI proteins.  
 
Figure 10: Overexpression of the murine ORAI1, ORAI2L, ORAI2S, GAMMA1 and GAMMA2 in 
two different cell backgrounds. HEK 293 (A-D) and RBL 2H3 (E-H) cells were transfected either 
with STIM1 alone (S1) or with STIM1 plus ORAI1 (S1+O1), ORAI2L (S1+O2L), ORAI2S (S1+O2S), 
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GAMMA1 (S1+G1) and GAMMA2 (S1+G2). Transfected cells that did not express the 
transfection marker GFP as well as non-transfected cells were used as controls (CTRL). 
Voltage-clamp ramps from +80 to -100 mV were delivered every 2 s to elicit ionic currents. 
Inward current densities were monitored at -90 mV. The activation of ionic currents was 
induced with IP3 (20 µM) under internal Ca2+-buffered conditions (10 mM EGTA) and in the 
presence of 5 mM external Ca2+. The time courses of inward currents densities (A, C, E, G) 
show the average development of ionic currents in 4 - 15 cells per transfection protocol. For 
clarity, the time courses display only every third data point. The current-voltage relationships 
(B, D, F, H) show representative recordings obtained 40 s after break-in. The individual 
transfection is indicated close to each trace.  
 
Co-expression of STIM1 and ORAI1, ORAI2L or ORAI2S induced clearly detectable 
CRAC currents in both, HEK 293 and RBL 2H3 cells showing the hallmark inward-
rectifying current-voltage characteristic of CRAC currents (Fig. 10 B, F). Cells 
transfected with STIM1 plus ORAI2L or ORAI2S showed an immediate current 
increase after break-in followed by a plateau phase that remained stable for at least 
100 s. The ionic currents measured in STIM1 + ORAI1 overexpressing cells show a 
spontaneous inactivation (Fig. 10 A, E). Independently of the cell background the 
peak current densities followed the sequence ORAI1 > ORAI2L > ORAI2S in the co-
expression experiments with STIM1 (Fig. 11 A, B). In HEK 293 cells, the CRAC 
current densities measured after co-expression are significantly larger than those 
measured after individual overexpression of STIM1 (Fig. 11 A). In contrast, co-
overexpression of STIM1 and ORAI2L or ORAI2S in RBL 2H3 cells showed current 
densities comparable to STIM1-transfected cells (Fig. 11 B). This indicates that the 
overexpressed ORAI2 variants might not contribute to the functional CRAC channel 
resource in RBL 2H3 cells which express endogenous ORAI2 proteins36.  
 
In addition, I co-expressed the GAMMA subunits of the voltage-dependent Ca2+ 
channels which are structurally similar to ORAI proteins35 with STIM1 in HEK 293 
and RBL 2H3 cells to elucidate whether these proteins interfere with the function of 
STIM1 in forming or activating CRAC channels. As for the individual overexpression 
of STIM1, the co-expression of STIM1 with GAMMA 1 or GAMMA 2  induced a strong 
inward-rectifying, fast activating current (Fig. 10 C, D, G, H). In RBL 2H3 cells, I 
observed a similar increase in current densities compared to individually STIM1-
transfected cells (Fig. 11 B) which was also true in transfected HEK 293 cells (Fig. 11 
A). Thus, despite the structural similarities between GAMMA and ORAI proteins35, 
the overexpression of GAMMA 1 and GAMMA 2 did not interfere with the function of 
CRAC channels. 
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Figure 11: Comparison of inward current densities in cells over-expressing murine ORAI, 
GAMMA and STIM1 proteins. HEK 293 (A) and RBL 2H3 (B) cells were transfected with STIM1 
(S1), ORAI1 (O1), ORAI2L (O2L), ORAI2L (O2S), GAMMA1 (G1) and GAMMA2 (G2) either 
individually or in combination, as indicated. Transfected cells that did not express the 
transfection marker GFP as well as non-transfected cells were used as controls (CTRL). Inward 
current densities were measured at -90 mV in experiments similar to those shown in Fig. 10 
and, for statistical analysis, current densities obtained 40 s after break-in were used. The levels 
for detection of ionic currents through channels formed by the transfected ORAI proteins are 
indicated with dashed lines and correspond to the mean current densities measured after 
transfection of STIM1 alone in HEK 293 (A) and RBL 2H3 (B) cells. The number of cells is given 
in parenthesis. 
 
In further experiments, I explored the effects of transfecting ORAI1, ORAI2L and 
ORAI2S individually. The endogenous ICRAC was not enhanced by the individual 
overexpression neither in HEK 293 nor in RBL 2H3 cells (Fig. 11 A and B). Due to 
hardly detectable endogenous CRAC current densities in HEK 293 cells, possible 
inhibitory effects could not be observed (Fig. 11 A). In contrast, overexpressed 
ORAI1, ORAI2L or ORAI2S attenuated the endogenous ICRAC in RBL 2H3 cells (Fig. 
11 B), suggesting that ORAI2L and ORAI2S, as well as ORAI1 interact with 
endogenous CRAC channels in these cells.  
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4.1.1 Internal Ca2+ rise inactivates CRAC currents 
 
HEK 293 cells overexpressing STIM1 and ORAI1, ORAI2L or ORAI2S showed that 
CRAC current densities strongly depend on the transfected ORAI isoform (Fig. 11 A). 
During these experiments, I additionally observed an inactivation of CRAC currents 
over time, which was more prominent in cells overexpressing STIM1 plus ORAI1 than 
in cells transfected with STIM1 plus an ORAI2 variant (Fig. 10 A). Therefore, I 
investigated whether the different levels of CRAC current densities reflected 
differences in the Ca2+-dependent inactivation previously reported for endogenous 
ICRAC 81, 82. In this series of experiments, internal Ca2+ levels were buffered with 
BAPTA instead of EGTA. Under these conditions almost no inactivation of CRAC 
currents could be observed in HEK 293 overexpressing STIM1 plus ORAI1 or ORAI2 
variants (Fig. 12 A, C, E), suggesting that the current decay observed under EGTA 
buffered conditions reflected a Ca2+-dependent inactivation process. To evaluate the 
amount of CRAC current inactivation (ΔI80) in the individual cells the recorded current 
densities at 80 s after break-in were subtracted from the peak current densities 
(IPeak). By plotting IPeak vs ΔI80, a direct relationship between the CRAC current 
densities and the current inactivation over time is clearly apparent in STIM1 and 
ORAI1 overexpressing cells under internal EGTA conditions (Fig. 12 B), indicating 
that the amount of current inactivation is proportional to the Ca2+ influx through ORAI 
proteins. In the experiments with BAPTA,  the ΔI80 to IPeak relationship is shifted to 
higher IPeak values in such a way that CRAC current inactivation was detectable 
starting at IPeak >30 pA/pF (Fig. 12 B). In the majority of cells with IPeak <30 pA/pF, 
inactivation of CRAC currents was almost abolished by BAPTA. A similar analysis of 
the CRAC currents in cells overexpressing STIM1 plus ORAI2L showed that BAPTA 
almost completely prevents the inactivation of CRAC currents, probably because IPeak 
current densities higher than 30 pA/pF, were not detectable in these cells (Fig. 12 D).  
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Figure 12: Ca2+ dependent inactivation of CRAC currents in cells over-expressing ORAI1, 
ORA2L and ORAI2S. HEK 293 cells were transfected with STIM1 plus ORAI1 (S1+O1), ORAI2L 
(S1+O2L) and ORAI2S (S1+O2S). In addition to 20 µM IP3, the pipette solution contained either 
10 mM EGTA or 10 mM BAPTA as indicated. The activation of CRAC currents was monitored 
using inward current densities at -90 mV. Average time courses of CRAC current activation in 
cells over-expressing STIM1 plus ORAI1 (A, n=12), ORAI2L (C, n=11) and ORAI2S (E, n=10) and 
dialysed with BAPTA are shown superimposed on time courses observed in cells dialysed with 
EGTA (same experiments as in Fig. 10 A). The external solution contained 5 mM Ca2+. The 
amount of CRAC current inactivation (ΔI80) was measured in individual cells as the peak current 
density (IPeak) subtracted by the current density obtained 80 s after break-in. ΔI80 is plotted vs. 
IPeak for cells transfected with STIM1 plus ORAI1 (B), ORAI2L (D) and ORAI2S (F). Symbols 
represent individual cells dialysed either with EGTA (open symbols) or BAPTA (closed 
symbols) and lines are approximated fittings to the data.  
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 Interestingly, peak currents recorded under EGTA or BAPTA conditions did not 
statistically differ from each other in STIM1 plus ORAI1 or ORAI2L co-expressing 
HEK 293 cells (Fig. 12 A, C). In cells overexpressing STIM1 plus ORAI2S, however, 
the CRAC current densities measured with BAPTA were 2.6 – 3.0-fold larger than 
those recorded with EGTA (Fig. 12 E). Cells overexpressing STIM1 plus ORAI2L or 
ORAI2S showed similar current density levels under BAPTA conditions (Fig 12 C, E). 
Although there was a considerable scatter in the ΔI80 to IPeak plots, the effect of 
BAPTA on the CRAC current inactivation were detectable in individual cells co-
expressing STIM1 and ORAI2S (Fig. 12 F).  
In summary, the experiments with BAPTA indicated that this Ca2+ chelator largely 
prevented CRAC current inactivation over time in cells overexpressing STIM1 plus 
ORAI1 or ORAI2L. More importantly, CRAC current densities in cells co-expressing 
STIM1 and ORAI2S were significantly increased under BAPTA conditions in 
comparison to EGTA buffered pipette solution. 
 
4.1.2 Na+ currents through murine ORAI isoforms 
 
Since ORAI2L and ORAI2S failed to enhance CRAC currents in RBL 2H3 cells as 
shown in Fig. 11 B, I further tested whether these ORAI2 variants modify the 
capability of endogenous CRAC channels to conduct Na+ currents (INa) in RBL 2H3 
cells. Fig. 13 A illustrates that the exchange of Ca2+- and Mg2+-containing 
extracellular solution to divalent free (DVF) solution results in a strong Na+ influx 
through CRAC channels81, 82. Subsequent reperfusion of the divalent containing 
solution showed the anomalous mole fraction effect and exposure to a nominally 
Ca2+-free solution (NCaF) completely abolished the Ca2+ current flow through CRAC 
channels. This indicates that the main charge carrier of ionic currents recorded in 
Ca2+-containing solution were Ca2+ ions (ICa). Similar responses were observed in 
perfusion experiments with RBL 2H3 cells co-expressing STIM1 plus ORAI1 or 
ORAI2 variants (Fig. 13 B, C, D). These perfusion experiments displayed the typical 
I-V-characteristics for Ca2+ and Na+ currents through CRAC channels11, 21, 83, 
exemplarily shown for STIM1 plus ORAI2L overexpressing cells (Fig 13 E). 
Furthermore, I measured the ratios INa/ICa to determine whether the proportionality 
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between Na+ and Ca2+ current densities is modified by the over expression of STIM1 
plus ORAI isoforms. Both, in control cells as well as in RBL 2H3 cells overexpressing 
STIM1 plus ORAI2 variants, the average INa/ICa ratios were in the range of 2 - 4 (Fig. 
13 F), indicating that the overexpression of ORAI2 isoforms did not modify the 
capability of endogenous CRAC currents to conduct Na+ ions. The same is true for 
RBL 2H3 cells co-expressing STIM1 plus ORAI1 (Fig. 13 F). 
  
Figure 13:  Na+ and Ca2+ currents in cells over-expressing the murine ORAI1, ORA2L and 
ORAI2S and non-transfected RBL 2H3 cells. RBL 2H3 cells were transfected with STIM1 plus 
ORAI1 (S1+O1), ORAI2L (S1+O2L) and ORAI2S (S1+O2S). Controls (CTRL) were transfected 
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cells that did not express the transfection marker GFP. Representative examples of 
experiments with a control cell are shown. (A), RBL 2H3 cells over-expressing ORAI1 plus 
STIM1 (B), ORAI2L plus STIM1 (C) and ORAI2S plus STIM1 (D). The external solution contained 
10 mM Ca2+ and was present in the external solution except as otherwise indicated. The 
nominally Ca2+ free solution (NCaF) containing no divalent cations and the divalent free 
solution (DVF) containing 10 mM EDTA were superfused as indicated above the traces. The 
recording pipette contained IP3 (20 µM) and BAPTA (10 mM). Ca2+ (ICa) and Na+ (INa) current 
amplitudes were determined at -90 mV in the presence of the 10 mM Ca2+ and DVF solutions, 
respectively. Representative I-V- characteristics are shown for Ca2+ current (E, black) and Na+ 
current (E, grey) through CRAC channels in STIM1 plus ORAI2L overexpressing RBL 2H3 cells. 
The average ratios INa/ICa obtained in control and transfected cells are shown (F). The number 
of cells is given in parenthesis. 
 
4.1.3 Influence of ORAI2 proteins on CRAC currents carried by ORAI1  
 
Cells overexpressing ORAI2L and ORAI2S exhibit lower CRAC current densities than 
cells overexpressing ORAI1, independently of whether internal Ca2+ was chelated by 
EGTA or BAPTA (Fig. 11 and 12). Since it has been shown that ORAI proteins form 
heteromultimeres84, I tested whether ORAI2 variants alter the functional expression 
of ORAI1 in triple transfection experiments in HEK 293 cells (Fig. 14).  The plasmid 
ratio STIM1:ORAI1 was 1:2 (Fig. 10, A and Fig. 11, A) and low amounts of the 
previously mentioned ORAI2L or ORAI2S plasmids were added to obtain the triple 
combinations STIM1:ORAI1:ORAI2L and, respectively, STIM1:ORAI1:ORAI2S at a 
ratio of 1:2:1. Accordingly, cells transfected with STIM1 and ORAI1 were used as 
controls. The CRAC current densities of cells transfected with STIM1, ORAI1 and 
ORAI2S were lower than the current densities in cells co-expressing STIM1 plus 
ORAI1. This pointed to a possible interference of ORAI2S with the functional 
expression of ORAI1 (Fig. 14, A). The maximum current densities of STIM1, ORAI1 
and ORAI2L transfected HEK 293 cells were in the same range as the STIM1 plus 
ORAI1 cells. The current voltage relationships for each set of triple transfections were 
indistinguishable from the I-V-characteristics for STIM1 and ORAI1 transfected cells 
(Fig. 10, B and Fig. 14, B) showing a strong inward rectifying current with a reversal 
potential in the highly positive voltage range. Additionally, ion current development 
over time was clearly changed under internal EGTA conditions. STIM1, ORAI1 and 
ORAI2L as well as STIM1, ORAI1 and ORAI2S transfected cells did not show the 
Ca2+-dependent inactivation compared to STIM1- and ORAI1-overexpressing cells 
HEK 293. Interestingly, each triple transfection perfectly resembled the current 
development over time of its STIM1 plus ORAI2 variant counterpart (Fig. 12, C, D 
and Fig. 14, A). 
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Figure 14: Co-expression of ORAI1 with ORAI2 variants. HEK293 cells were transfected with 
STIM1, ORAI1 and either ORAI2L (S1+O1+O2L) or ORAI2S (S1+O1+O2S) at a ratio of 1:2:1. Cells 
transfected with STIM1 plus ORAI1 (S1+O1) at a ratio of 1:2 (same experiments as in Fig. 10 A) 
served as controls. The pipette solution contained 20 µM IP3 plus 10 mM EGTA and the external 
solution contained 5 mM Ca2+. The activation of CRAC currents was monitored using inward 
current densities at -90 mV. (A) Average time courses of CRAC current activation in cells over-
expressing STIM1 plus ORAI1 and ORAI2L (n=8) or ORAI2S (n=9) are shown superimposed on 
the time course observed in cells transfected with STIM1 plus ORAI1.  
(B) Representative current-voltage relationships of cells co-expressing ORAI1 and ORAI2 
variants. The transfection protocols are indicated close to the traces. 
 
4.1.4 The murine ORAI2S (N130Y) variant 
 
As mentioned in the introduction, U. Wissenbach detected a third ORAI2 variant in 
mice named ORAI2S (N130Y) that corresponds to ORAI2S with the amino acid 
exchange N130Y35. HEK 293 cells transfected with STIM1 and ORAI2S (N130Y) at a 
ratio 1:2 showed an inward rectifying current after store depletion by internal IP3 
comparable to the currents observed in STIM1 plus ORAI2S overexpressing cells 
(Fig. 10 B and Fig. 15 B). Thus, both ORAI2S variants developed ICRAC with a higher 
current density for the ORAI2S (N130Y) (~-8 pA/pF) in comparison to cell 
overexpressing STIM1 plus ORAI2S (~-5 pA/pF). These findings indicate that both 
gene transcripts generate functional channel proteins (Fig. 10 A and Fig. 15 A).  
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Figure 15: Over-expression of STIM1 and the ORAI2S (N130Y) sequence from the murine orai2 
locus on chromosome 16. HEK 293cells were transfected with STIM1 and ORAI2S (N130Y) 
plasmids. The activation of ionic currents was induced with IP3 (20 µM) in 0 Ca2+ (with EGTA) 
internal solution and in the presence of 5 mM external Ca2+. The time course of inward current 
densities (A) shows the average development of ionic currents at -90 mV in 13 transfected 
cells. The current-voltage relationship (B) is a representative recording obtained 40 s after 
break-in.  
 
4.1.5 Non-functional murine ORAI proteins   
 
Feske et al. first described that a mutation in ORAI1 protein causes immune 
deficiency by abrogating CRAC channel function. The mutated ORAI1 protein was 
named ORAI1 Scid8 (detailed information can be found on page 23ff). I generated the 
amino acid substitution from arginine to tryptophan at position 91 in murine ORAI1 
and the arginine to tryptophan substitution at position 78 in murine ORAI2S proteins 
according to the human ORAI1 Scid mutation and investigated the resultant 
functional properties. Whole-cell recordings revealed prominent CRAC currents in 
STIM1 plus ORAI1 or ORAI2S co-expressing HEK 293 cells induced by the dialysis 
of 20 µM IP3, but hardly any current development was observed in cells transfected 
with STIM1 plus ORAI1 Scid or STIM1 plus ORAI2S Scid, respectively (Fig. 16 A). 
Notably, the ORAI1 Scid and ORAI2S Scid proteins appeared to have a dominant-
negative effect on endogenous CRAC currents in HEK 293 cells, supporting the 
concept of a multimeric ORAI protein assembly to form a functional ion channel33, 35 
(Fig. 16 B).  
In summary, the average current densities in cells overexpressing STIM1 plus ORAI1 
Scid or ORAI2S Scid were close to the resolution limit of whole-cell recordings and 
smaller than endogenous ICRAC in HEK 293 cells or CRAC current density in HEK 293 
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cells overexpressing STIM1 (Fig. 16 C). Murine ORAI1 and ORAI2S Scid mutations 
represent the non-functional counterpart to previously described human ORAI1 Scid8. 
      
 
Figure 16: Non-functional murine ORAI1 Scid (S1 O1 Scid) and ORAI2S Scid (S1 O2S Scid) 
proteins co-transfected in HEK 293 cells with STIM1 in comparison to transfections of STIM1 
plus ORAI1 (S1 O1) or ORAI2S (S1 O2S), STIM1 (S1) and non-transfected control HEK 293 cells 
(CTRL). (A) and (B) Average current development over time induced by 20 µM internal IP3 in 5 
mM Ca2+ containing external solution. Current densities were recorded at -90 mV in whole-cell 
patch clamp configuration. (C) Current densities 80 s after break-in. The number of cells is 
given in parenthesis. 
 
4.1.6 Neuronal expression of ORAI proteins 
 
CRAC currents have been studied extensively in hematopoietic cells, but there are at 
present no detailed studies in non-hematopoietic cells due to the fact that 
endogenous CRAC currents are hard to detect81 in these cells. In contrast, STIM1 
and ORAI transcripts and proteins, respectively, were detected in virtually every cell 
type including cortical neurons35. To demonstrate that neurons express ORAI 
proteins, single cells isolated from murine cortex were identified as neurons by 
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whole-cell recordings of voltage-gated Na+-currents (Fig. 17 A) and subsequently 
each cell was collected in an individual PCR tube and immediately stored in liquid 
nitrogen. The mRNA served as a template for reverse transcription and PCR. This 
approach resulted in the detection of 5 out of 13 single neurons expressing ORAI2L 
transcripts (Fig. 17 C by S.A. Gross and U. Wissenbach). In contrast, no CRAC 
current in cortical neurons was observed in whole-cell patch clamp experiments (Fig. 
17 A). As illustrated in Fig. 17, common store-depleting reagents were used to induce 
CRAC currents in murine cortical neurons. Neither dialysis with IP3 nor ionophores 
such as 4-BrA23187 or Ionomycin could activate ICRAC resulting in extremely small, 
rather linear currents showing inward current densities smaller than -0.5 pA/pF 80 s 
after break-in (Fig. 17, A, B). 
 
 
Figure 17: Expression of ORAI2L and functional tests for CRAC currents in cortical neurons. 
(A) Representative current-voltage relations obtained with experimental protocols designed to 
detect CRAC currents (i) and voltage-dependent sodium currents (ii). (B) Average current 
densities measured at -90 mV 80 s after establishing the whole-cell configuration in neurons 
(c1 – c13) were dialysed with 20 µM IP3 (n=7), 200 nM 4-BrA23187 (n=3) and 5 µM ionomycin 
(n=5). The densities of voltage-dependent sodium currents (Na+ current) were determined at -10 
mV (n=7). (C) by S. A. Gross and U. Wissenbach35. Thirteen independent isolated murine 
cortical neurons identified by whole-cell recordings of voltage-gated Na+-currents. The 
cytoplasm of each individual cell was sucked into the patch pipette and transferred to single 
PCR tubes and analysed for the expression of ORAI2L. For positive controls, primers were 
used to amplify the cDNA of glutamic acid decarboxylase (GAD67). Co, no template control. 
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4.2 Functional interactions between STIM1, ORAI and TRPC 
proteins 
 
CRAC currents are a subpopulation of inward Ca2+ currents of the so called SOCE 
(store-operated Ca2+ entry) or ROCE (receptor-operated Ca2+ entry) type5, 85-90. 
Besides the strong evidence that ORAI proteins form CRAC channels8, 9, 33, 34, 91 
activated by STIM1 translocation11, 12 (see also section 4.1), the canonical transient 
receptor potential (TRPC) ion channel subfamily are believed to be involved in both 
SOCE and ROCE38, 92, 93. In the present study, I investigated whether there is a 
functional interaction between TRPC, STIM1 and ORAI proteins. For this purpose, 
HEK 293 cells were transiently transfected with TRPC3 or TRPC5 plus STIM1 and 
ORAI1. Under these conditions, it was tested whether the depletion of internal Ca2+ 
stores activates TRPC3 and TRPC5 currents in addition to CRAC currents (Fig. 18).  
HEK 293 cells transfected with STIM1 plus ORAI1 and also HEK 293 cells 
transfected with STIM1, ORAI1 plus TRPC5 or TRPC3 were dialysed with 20 µM IP3 
to activate ICRAC. Since ICRAC in STIM1 plus ORAI1 overexpressing cells did not show 
any significant outward current at +80 mV (Fig. 10), the additional outward current 
development at +80 mV was used to monitor the possible activation of TRPC3 and 
TRPC5 channels (Fig. 18 A, B). In contrast to HEK 293 cells transfected with STIM1 
plus ORAI1, triple-transfected cells showed clearly detectable outward currents with 
average peak current densities of about 5 pA/pF (STIM1 + ORAI1 + TRPC3) and 
about 16 pA/pF (STIM1 + ORAI1 + TRPC5) in comparison to about 0.5 pA/pF for 
STIM1 plus ORAI1 overexpressing HEK 293 cells (Fig. 18 A). As illustrated in Fig. 
18, outward currents and inward currents at +80 mV and -80 mV, respectively, 
activated in parallel to each other in STIM1, ORAI1 plus TRPC3 overexpressing cells 
whereas in STIM1, ORAI1 and TRPC5 transfected HEK 293 cells, a delay in outward 
current development compared to inward current activation was observed. 
Furthermore, average inward current densities were larger in triple-transfected HEK 
293 cells (Fig. 18 A), indicating the additivity of CRAC and TRPC5 currents at 
negative potentials.  
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Figure 18: Co-activation of TRPC3, TRPC5 and CRAC currents by depletion of internal Ca2+ 
stores. HEK 293 cells were transiently transfected with STIM1 + ORAI1 (S1 O1), STIM1 + ORAI1 
+ TRPC3 (S1 O1 C3) and STIM1 + ORAI1 + TRPC5 (S1 O1 C5). Voltage clamp ramps from -100 
mV to +100 mV were applied every 2 seconds. (A) Average peak current densities for outward 
currents (at +80 mV) and inward currents (at -80 mV) measured 80 s after establishing the 
whole-cell configuration. The numbers of cells is given in parenthesis. (B) Inward and outward 
current development after dialysis with 20 µM IP3 under Ca2+-bufferd conditions (10 mM EGTA) 
in whole-cell patch clamp configuration. (C) Comparison of the inward (at -80 mV) and outward 
(at +80 mV) current development in S1 O1 C5 transfected HEK 293 cells. Current densities were 
normalized. (D) Comparison of the inward (at -80 mV) and outward (at +80 mV) current 
development in S1 O1 C3 transfected HEK 293 cells. Current densities were normalized.      
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Since TRPC3 and TRPC5 currents were activated by intracellular IP3 infusion in HEK 
293 cells co-transfected with STIM1 plus ORAI1 (Fig. 18) but did not show activation 
by IP3 when individually overexpressed (Fig. 19), it was tested whether the interplay 
of STIM1 and ORAI1 is essential for TRPC channel activation or whether either 
ORAI1 or STIM1 are sufficient. HEK 293 cells transfected with TRPC5 plus ORAI1 or 
STIM1 did not display clear ICRAC after dialysis with IP3 and TRPC5 outward currents 
failed to activate as well (Fig. 19 A, B). Similarly TRPC3 specific outward currents did 
not develop after the depletion of Ca2+ stores in co-transfection experiments with 
ORAI1 (Fig. 19 C, D). In HEK 293 cells overexpressing STIM1, ORAI2S and TRPC3, 
strong CRAC currents were observed but TRPC3 specific outward currents did not 
develop (Fig. 19 C, D). Unsurprisingly, HEK 293 cells transfected with ORAI2S plus 
TRPC3 showed neither ICRAC nor TRPC3 currents (Fig. 19 C, D). In summary, 
TRPC3 and TRPC5 currents were activated by internal dialysis with IP3 in HEK 293 
cells overexpressing STIM1 and ORAI1 plus TRPC3 or TRPC5. Although significant 
outward currents were observed in STIM1, ORAI1 and TRPC3 transfected HEK 293 
cells, TRPC5 current development in STIM1, ORAI1 and TRPC5 overexpressing 
cells was much more prominent (Fig. 18, 19). Therefore, from here on, my 
experiments focused on the functional interaction between STIM1, ORAI1 and 
TRPC5.  
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Figure 19: Functional interactions between STIM1, ORAI1, ORAI2S, TRPC3 and TRPC5 
proteins. HEK 293 cells were transfected with TRPC5 (C5), STIM1 + TRPC5 (S1 C5), ORAI1 + 
TRPC5 (O1 TRPC5), STIM1 + ORAI1 + TRPC5 (S1 O1 C5), ORAI1 + TRPC3 (O1 C3), ORAI2S + 
TRPC3 (O2S C3), STIM1 + ORAI1 + TRPC3 (S1 O1 C3) and STIM1 + ORAI2S + TRPC3 (S1 O2S 
C3). In whole-cell patch clamp experiments voltage clamp ramps from -100 mV to +100 mV 
were delivered every 2 seconds. (A, C) Statistical analysis of peak current densities for inward 
(-80 mV) and outward currents (+80 mV) measured 40 s after establishing the whole-cell 
configuration. Numbers of cells are given in parenthesis. (B, D) Inward and outward current 
development over time in experimental conditions as described in Fig. 18. 
 
The experiment shown in Fig. 20 illustrates the basic features observed in 
experiments with cells transfected with TRPC5, ORAI1 plus STIM1. Immediately after 
starting dialysis with IP3 and buffering internal Ca2+, ICRAC developed and revealed 
the hallmark inward-rectifying I-V-characteristic (Fig. 20 A, B i). After some seconds 
delay, TRPC5 outward currents were activated and I-V-characteristics changed from 
an ICRAC type to a typical TRPC5 current-voltage relationship (Fig. 20 A, B i) including 
a reversal potential shift from about +50 mV to approximately +5 mV (Fig. B ii), as it 
was expected, because TRPC5 forms non-selective cation channels94, while CRAC 
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channels are essentially Ca2+-selective channels21. Thus, the double-rectifying I-V-
shape of non-selective TRPC5 channels13, 55, 95 was clearly detected in HEK 293 
overexpressing STIM1, ORAI1 plus TRPC5.   
 
Figure 20: TRPC5 channel activation by internal IP3 in STIM1, ORAI1 and TRPC5 
overexpressing HEK 293 cells. (A) Representative current development over time. Displayed 
are inward current densities (-80 mV) and outward current densities (+80 mV) measured in 
whole-cell recordings by applying voltage clamp ramps from +100 mV to -100 mV every 2 
seconds. (B i) Current-voltage characteristics at different time points as indicated by arrows in 
(A). (B ii) Enlarged version of the I-Vs of (B i) showing the reversal potential shift as indicated 
by the black arrow. Experimental conditions as in Fig. 18. 
 
 
4.3 Functional coupling of TRPC5 to calcium-selective ion 
channels 
4.3.1 Local [Ca2+]i rise induced by CRAC currents activates TRPC5 
channels 
 
Two hypotheses provided a basis for the experiments designed to study the 
functional interaction between STIM1, ORAI1 and TRPC5. First, STIM1, ORAI1 and 
TRPC5 might interact directly with each other. Such protein-protein interactions have 
been reported66, 96-98 but the role of internal Ca2+ in the activation of TRPC5 channels 
has not studied in detail. Second, I considered the possibility that Ca2+ influx through 
ORAI1 induced the TRPC5 channel activation. TRPC5-stably transfected HEK 293 
cells, hereafter referred to as TRPC5 stable cells or the TRPC5 cell line, were used in 
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the following experiments, which were designed to study the role of internal Ca2+ in 
the activation of TRPC5 channels.  
First, the role of Ca2+ influx through CRAC channels in the activation of TRPC5 
channels was explored by removing external Ca2+ and using the non-functional ORAI 
Scid proteins (see section 4.1.5). The TRPC5 cell line co-expressing STIM1 and 
ORAI1 showed a clear inward-rectifying CRAC current upon activation by IP3 dialysis 
under intracellular Ca2+-buffered conditions (10 mM EGTA) (Fig. 21 B, D). The 
external solution contained 5 mM CaCl2. In immediate response to ICRAC activation, 
outward and additional inward currents developed (Fig. 21 A) showing the typical 
TRPC5 I-V-characteristic (Fig. 21 B). In contrast, TRPC5 stable cells transfected with 
STIM1 plus the non-functional ORAI1 Scid showed neither CRAC current nor TRPC5 
current development (Fig. 21 A). In order to test whether intact ORAI1 and TRPC5 
protein interaction is responsible for additional TRPC5 currents upon IP3 dialysis or 
whether the Ca2+ signal mediated by functional ORAI1 is the key component in 
TRPC5 activation, I performed comparable experiments under nominally Ca2+-free 
conditions (NCaF). As illustrated in Fig. 21 C i, STIM1 plus ORAI1-overexpressing 
TRPC5 stable cells showed neither ICRAC nor TRPC5 currents. As soon as a 5 mM 
Ca2+ containing external solution was perfused, ICRAC and TRPC5 currents developed 
(Fig. 21 C ii) showing typical I-V-characteristics (Fig. 21 D). As shown in Fig. 18, the 
activation of TRPC5 currents was clearly delayed compared to the rapid increase of 
ICRAC. Since TRPC5 currents disappeared due to NCaF reperfusion (Fig. 21 C ii), 
local [Ca2+]i rise was the likely to be the ultimate signal in the activation of TRPC5 
channels. To test this hypothesis, 10 mM BAPTA was added to the standard pipette 
solution to obtain a mix of 10 mM EGTA and 10 mM BAPTA. In previous studies of 
exocytosis in chromaffin cells, this mix of Ca2+ chelators efficiently buffer the fast 
Ca2+ transients99. In the presence of 5 mM external Ca2+, internal IP3 induced strong 
CRAC currents in STIM1 plus ORAI1 transfected TRPC5 cells but no TRPC5 
currents were observed (Fig. 22 A, B). Thus, the Ca2+ influx supported by CRAC 
channels likely induced a rise of local [Ca2+]I, which in turn activated TRPC5 channels 
in the experiments shown in Fig. 21.   
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Figure 21: Involvement of the Ca2+ influx through CRAC channels in the activation of TRPC5 
channels. TRPC5-stably transfected HEK 293 cells were transiently transfected with STIM1 + 
ORAI 1 (S1 O1) or STIM1 + ORAI1 Scid (S1 O1 Scid). Voltage ramps from -100 mV to +100 mV 
were applied every 2 s in the whole-cell patch clamp configuration. Inward and outward 
currents were measured at -80 mV and +80 mV, respectively.  (A) Inward and outward current 
development was recorded over time in the presence of 5 mM external Ca2+. Currents were 
activated by 20 µM internal IP3 in 10 mM EGTA buffered conditions. TRPC5 stable cells 
transfected with STIM1 + ORAI1 Scid did not activate under these conditions. (B) I-V-
characteristics for STIM1 + ORAI1 transfected TRPC5 cells at different time points of current 
development as indicated by numbers in (A). (C i)  STIM1 + ORAI1-transfected TRPC5 cell line 
was activated as described. Perfusion of nominally Ca2+-free solution (NCaF) prevented current 
activation. (C ii) Reperfusion of Ca2+-containing solution reversibly activated ICRAC and TRPC5 
currents. (D) I-V-characteristics for current development at different time points indicated by 
numbers in (C ii).  
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Figure 22: The rise of local [Ca2+]i induced by CRAC currents activates TRPC5 channels. A 
representative ion current development over time for STIM1 and ORAI1 overexpressing TRPC5 
stable cells in voltage clamp eperiments. Experimental conditions as described in Fig. 21 with 
the exception that 10 mM BAPTA were added to achieve maximal buffering of internal Ca2+.  (A) 
Current densities showing inward (-80 mV; black line) and outward currents (+80 mV; grey 
line). (B) Representative I-V-characteristic as indicated by numbers in (A).   
 
According to the triple transfection experiments with TRPC5, ORAI1 plus STIM1  
(Fig. 18, 19), the TRPC5 cell line was transfected individually with STIM1 or ORAI1 to 
test whether TRPC5 currents develop under these conditions in response to IP3 
dialysis (Fig. 23 A). The pipette solution contained 10 mM EGTA and cells were 
perfused with a 5 mM Ca2+-containing solution. The non-transfected TRPC5 cell line 
and the TRPC5 cells individually transfected with STIM1 or ORAI1 showed neither 
inward-rectifying CRAC currents nor TRPC5 development (Fig. 23 A). The detectable 
currents, seen under these conditions, represent linear background currents in 
TRPC5 stable cells. In contrast, average current densities for STIM1 plus ORAI1-
transfected TRPC5 stable cells showed initial high levels of inward current densities, 
indicating the activation of CRAC channels, followed by the activation of TRPC5 
channels as indicated by the increase high levels of late outward current densities 
(Fig. 23 A). Thus, as in the transiently transfected HEK 293 cells (Fig. 18, Fig. 19), 
the activation of TRPC5 channels in the TRPC5 cell line required the presence of 
both ORAI1 and STIM1. 
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Figure 23: Activation of CRAC and TRPC5 channels and correlation between CRAC and TRPC5 
currents in the TRPC5 cell line. STIM1 + ORAI1 (S1 O1), ORAI1 (O1) or STIM1 (S1) were 
transfected in the TRPC5 cell line. Ton-transfected cells (TRPC5 stable) were used as controls. 
Cells were dialysed with IP3 under buffering of internal Ca2+ with 10 mM EGTA and ion currents 
were measured in the presence of 5 mM external Ca2+ as described in Fig. 21 A. (A) Average 
inward (-80 mV) and outward (+80 mV) currents recorded 30 s and 50 s after establishing 
whole-cell patch configuration. The inward currents recorded at 30 s represent likely pure 
CRAC currents while the outward currents measured at 50 s correspond to TRPC5 currents. 
Cell numbers are given in parenthesis. Error bars indicate s.e.m. (B) CRAC current (-80 mV, 30 
s) plotted versus TRPC5 outward currents (+80 mV, 50 s) for the TRPC5 cell line transfected 
with STIM1 plus ORAI1.  
 
Finally, the relationship between Ca2+ influx mediated by ORAI1 and TRPC5 outward 
currents was analyzed in more detail. I tested whether the TRPC5 current densities 
are related to CRAC current densities, which likely represent a measure for the 
amount of Ca2+ influx into the cells. In Fig. 23 B, CRAC TRPC5 outward current 
densities monitored at +80 mV were plotted versus inward current densities 
monitored at -80 mV recorded in TRPC5 cells transfected with STIM1 plus ORAI1. 
Inward currents were recorded 30 s after break-in when ICRAC was clearly detectable 
but TRPC5 was still inactive (Fig. 23 A) and TRPC5 outward current densities 
represent peak TRPC5 currents ~50 s after establishing whole-cell configuration (Fig. 
23 A). As expected from the experiments shown in Fig. 18 and 21, in which CRAC 
current activation preceded the activation of TRPC5 currents, a correlation between 
TRPC5 outward current development and the CRAC current densities was found in 
individual cells (Fig. 23 B). This clearly supports the hypothesis for a direct and dose-
dependent effect of intracellular Ca2+ on TRPC5 channel activation.  
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4.3.2 Intracellular Ca2+ activates TRPC5 currents   
 
The activation of TRPC5 currents was dependent on the [Ca2+]i rise induced by Ca2+ 
influx through CRAC channels in the TRPC5 cell line transfected with STIM1 plus 
ORAI1 (Fig. 23 B). Accordingly, it was tested whether TRPC5 currents are also 
activated by dialysing the cells with various [Ca2+]i. In these experiments, pipette 
solutions containing EGTA-buffered Ca2+ concentrations of 0, 10, 30, 50, 100, 300, 
500, 1000, 3000 and 10000 nM were used to establish appropriate dose-response 
relationships for inward (-80 mV) and outward current densities (+ 80mV) (Fig. 24 C, 
D). Ca2+ was not added to the external solution. Immediately after establishing the 
whole-cell configuration and, accordingly, the dialysis with Ca2+, a rapid increase of 
both outward and inward currents was observed depending on the [Ca2+]i (Fig. 24 A). 
Current-voltage characteristics clearly showed the typical TRPC5 shape (Fig. 24 B) 
indicating that TRPC5 is exclusively activated in the TRPC5 cell line. In order to 
determine the dose-response relations, peak inward and outward currents from the 
experiments shown in Fig. 24 A were plotted versus [Ca2+]i (Fig. 24 C, D). The data 
was subsequently fitted with Hill equations (Table 4). Both inward and outward 
currents were not affected by [Ca2+]i below 100 nM and maximal current densities 
were attained with [Ca2+]i above 1000 nM. The EC50 values (Table 4) indicated that 
outward currents were more sensitive to changes of [Ca2+]i. In order to test whether 
the recorded currents were mediated by TRPC5 channels expressed in the TRPC5 
cell line, dialysis of various [Ca2+]i was performed in control HEK 293 cells. At [Ca2+]i 
as high as 10000 nM, only linear leak currents were observed (not shown). The 
analysis of the experiments with HEK 293 cells indicated that inward and outward 
leak currents were not Ca2+ dependent (Fig. 24 C, D). Furthermore, it was tested 
whether STIM1 modifies the Ca2+-dependence of TRPC5 channels. In these 
experiments, STIM1 was transiently transfected into the TRPC5 cell line. As shown in 
Fig. 24 C and D, a slight increase of inward and outward currents at [Ca2+]i higher 
than 100 nM was observed. Accordingly, there was a shift of Ca2+ dose-response 
relations to lower [Ca2+]i in STIM1 expressing cells when compared to the TRPC5 
stable cell line and the EC50 values decreased (Table 4). 
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Figure 24: Dose-response relationship for the activation of TRPC5 currents by internal Ca2+ in 
the TRPC5 cell line. (A) TRPC5 current development in cells dialysed with [Ca2+]i between 0 nM 
and 10000 nM as indicated. Voltage clamp ramps were delivered every 2 s from -100 mV to 
+100 mV. Current densities were measured at +80 mV (outward currents) and -80 mV (inward 
currents). (B) I-V-relations for representative experiments at the indicated [Ca2+]i. (C, D) Dose-
response relationships for inward and outward current increase induced by various [Ca2+]i, 
respectively. Data were obtained using HEK 293 cells (CTRL), TRPC5 stable cells (C5) and 
TRPC5 cell line transiently transfected with STIM1 (S1 C5). The fittings were performed with the 
Hill equation with the parameters given in Table 4. (E) Inward to outward current ratios for 
various [Ca2+]i. n: 4 – 10.    
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Table 4: The dose-response relations for the Ca2+ dependent activation of TRPC5 currents 
(Fig. 24 A, B) were fitted with Hill equations. The parameters are given below for the TRPC5 
cell line (TRPC5) and for TRPC5 cell line transfected with STIM1 (TRPC5 + STIM1. 
 
 Parameters TRPC5 TRPC5 + STIM1 
min (pA/pF) -0.183 ± 2.68 -2.818 ± 6.85 
max (pA/pF) -122.27 ± 4.64 -149.67 ± 9.31 
Hill coefficient 1.248 ± 0.158 1.638 ± 0.457 
inward current 
densities 
(-80 mV) 
EC50 (nM) 635.11 ± 60.8 456.33 ± 72.4 
min (pA/pF) 7.676 ± 3.95 7.574 ± 10.2 
max (pA/pF) 137.9 ± 4.93 160 ± 0 
Hill coefficient 2.614 ± 0.601 1.898 ± 0.589 
outward 
current 
densities 
(+80 mV) EC50 (nM) 358. 2 ± 28.8 260.06 ± 51.6 
 
Furthermore, I determined the ratio between inward and outward currents activated 
by internal Ca2+ in the TRPC5 cell line and the transiently STIM1-transfected TRPC5 
cell line, in order to see whether the rectification properties of TRPC5 channels is 
modulated by [Ca2+]i and STIM1. Inward to outward current ratios of both the non-
transfected and STIM1-transfected TRPC5 stable cells were dependent on internal 
Ca2+ levels, increasing from 50 % to ~90 % upon raising internal Ca2+ from 100 nM to 
10 µM (Fig. 24 E). This suggests, that the outward currents are more sensitive to 
changes in [Ca2+]i when compared to inward currents (Table 4).  
In Fig. 24 A, TRPC5 activation was accelerated by increasing internal Ca2+ levels in 
both non-transfected and STIM1-transfected TRPC5 stable cells. Additionally, 
TRPC5 currents were observed to inactivate in a Ca2+-dependent manner (Fig. 24 A). 
Interestingly, the inactivation of both inward and outward TRPC5 currents was 
modified by the expression of STIM1 in the TRPC5 cell line. The higher the internal 
Ca2+ concentration the larger is the STIM1 effect on TRPC5 run down (Fig. 25 A). For 
instance, in the presence of 1 µM [Ca2+]i outward and inward currents inactivated with 
a time constant (t1/2) of 36 s in the TRPC5 cell line and the expression of STIM1 
significantly slowed down the inactivation of TRPC5 currents in a way that the time 
constant of inactivation almost doubled to 64 s (Fig. 25 B). In summary, inward and 
outward TRPC5 currents were activated by [Ca2+]i in a dose-dependent manner. 
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STIM1 slightly enhanced the sensitivity of TRPC5 currents to internal Ca2+ and, 
additionally, slowed down the inactivation that was also Ca2+-dependent.  
        
 
Figure 25: Normalized TRPC5 current development over time in non-transfected (black) and 
STIM1-transfected TRPC5 stable cells (grey) in response to various internal Ca2+ 
concentrations. (A) Same experiments as in Fig. 24 A. At [Ca2+]i higher than 300 nM, both 
outward and inward currents showed a prominent inactivation. (B) The time for half maximal 
inactivation (t1/2) is given for 1 µM [Ca2+]i. n: 5 -  6.  
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4.3.3 The role of internal Ca2+ in the activation of TRPC5 currents via 
membrane receptors 
 
Since previous reports suggested that TRPC5 currents activate upon application of 
receptor-stimulating agonists such as carbachol (CCH)100, 101, I investigated the 
interplay between the effects of receptor-stimulation and dialysis of defined [Ca2+]i on 
TRPC5 currents. Upon application of 200 µM CCH, TRPC5 currents increased 
rapidly when [Ca2+]i was 100 nM (Fig. 26 A, B). Clearly, these CCH-stimulated 
TRPC5 currents were larger and developed faster than those that were activated by 
100 nM [Ca2+]i (Fig. 24 A and Fig. 26 A). CCH-activated TRPC5 currents were 
completely inhibited by buffering intracellular calcium to 0 nM (Fig. 26 A). Further 
experiments showed that Ca2+-activated TRPC5 currents were reversibly boosted by 
carbachol perfusion (Fig. 26 C, D). In these experiments, 1000 nM [Ca2+]i was used 
to attain maximal activation of TRPC5 currents. Carbachol induced an additional 
TRPC5 current increase which was reversed by reperfusing the cells with a 
carbachol-free external solution. The effects of CCH on TRPC5 currents, even 
though smaller, were reproduced by a second carbachol reperfusion (Fig. 26 C). 
Notably, average inward current boost was significantly larger than average outward 
current boost, as shown in Fig. 26 E. With 1 µM [Ca2+]i, inward current densities 
increased at ~150 % in size upon charbachol perfusion, whereas outward current 
densities showed a clear 50 % increase (Fig. 26 E).  In HEK 293 control cells, neither 
CCH nor the increase of [Ca2+]i activated ion currents (Fig. 26 C). As illustrated in 
Fig. 28 B, carbachol-induced increase of TRPC5 currents was dependent on 
intracellular Ca2+ concentrations with the strongest CCH-effect at physiological [Ca2+]i 
levels. Since the CCH-effects were absent in the presence of 10 mM EGTA, the 
present results suggest that the rise of [Ca2+]i might be a central event in the 
activation of TRPC5 channels via stimulation of membrane receptors.  
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Figure 26: Activation of TRPC5 currents by stimulation of muscarinic receptors under defined 
[Ca2+]i. Whole cell voltage clamp recordings as previously described in Fig. 25. Inward currents 
were measured at -80 mV, outward currents at +80 mV. Carbachol (CCH, 200 µM) was applied 
as indicated above the graph. (A) Average inward and outward current densities in the TRPC5 
cell line stimulated with CCH at the indicated [Ca2+]i. For comparison, the time courses of 
inward and outward currents activated with 100 nM [Ca2+]i are shown (same experiments from 
Fig. 24 A). (B) Representative I-V-characteristic for CCH activated TRPC5 currents in the 
presence of 100 nM intracellular Ca2+. (C) Representative inward and outward TRPC5 current 
development over time induced by 1 µM [Ca2+]i and, additional stimulation with CCH: TRPC5 
stable cells (TRPC5 stable; black line) and HEK 293 control cells (HEK 293; grey line). (D) 
Representative I-V-characteristics recorded at indicated time points in (C). (E) Average 
increase of TRPC5 currents induced by CCH with respect to the current densities attained by 
the activation with 1 µM [Ca2+]i. n = 3.    
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It has been reported that TRPC5 currents increased dramatically by a phenomenon 
called ‘rapid vesicular insertion of TRP’ channels (RiVIT), which means that vesicular 
TRPC5 channel proteins translocate and insert into the cell membrane upon 
epidermal growth factor (EGF) stimulation60. In addition, exocytotic processes, such 
as vesicular translocation, are also triggered by increased internal Ca2+ levels102. 
Since TRPC5 currents were activated by internal Ca2+ in a dose-dependent manner 
(Fig. 24 A, C, D), I tested the effects of EGF and various [Ca2+]i in the TRPC5 cell 
line. In these experiments, the cells were incubated with 100 ng/ml EGF for 4 min to 
produce exocytotic events60 and, afterwards, the effects of rising [Ca2+]I were tested. 
As for cells dialysed with various [Ca2+]i (Fig. 24), the EGF-treated cells developed 
outward and inward currents with time courses that were dependent on dialysed 
[Ca2+]i (Fig. 27 A, B). Additionally, EGF-treated TRPC5 stable cells revealed an 
increase in inward (at -80 mV) and outward current densities (at +80 mV) for 
intracellular Ca2+ concentrations from 100 nM to 3000 nM (Fig. 27 A, B). Under sub-
physiological intracellular [Ca2+]i, EGF incubation did not induce a detectable TRPC5 
current (Fig. 27 A, B). Accordingly, a decrease of the EC50 value for the Ca2+-
dependence of TRPC5 outward currents to lower [Ca2+]i was detected in EGF-treated 
cells (Table 5).  In conclusion, EGF-induced TRPC5 currents were slightly more 
sensitive to intracellular Ca2+ rise in EGF-treated cells but current densities were not 
significantly different over the [Ca2+]i range of 10 – 10000 nM (Table 5, Fig. 27 C). 
 
Figure 27: Effects of various [Ca2+]i on TRPC5 currents in cells stimulated with EGF and non-
stimulated cells. Cells stably transfected with TRPC5 were incubated with EGF (100 ng/ml) for 4 
min at 37°C before establishing the whole-cell configuration to record outward and inward 
TRPC5 currents using [Ca2+]i as described in Fig. 24. Outward currents were measured at +80 
mV and inward currents were measured at -80 mV. (A, B) Average inward and outward TRPC5 
current development, respectively. The [Ca2+]i used in the pipette solutions are indicated. (C) 
Dose-response relationship for the effects of internal Ca2+ in EGF-treated cells (black) and non-
treated (grey) TRPC5 cells. Lines represent dose response fits with the Hill equation with the 
parameters given in Table 5.  n: 4 – 8.  
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Table 5: The dose-response relationship for the Ca2+ dependent activation of TRPC5 
outward currents in the EGF-treated TRPC5 cell line (Fig. 27 B) was determined by a Hill 
equation fit. The parameters are given below for the TRPC5 cell line (TRPC5) and for the 
EGF-treated TRPC5 cell (EGF-treated STIM1). 
 
 Parameters TRPC5 EGF-treated TRPC5 
min (pA/pF) 7.676 ± 3.95 9.518 ± 14 
max (pA/pF) 137.9 ± 4.93 203.41 ± 18 
Hill coefficient 2.614 ± 0.601 1.503 ± 0.515 
outward 
current 
densities 
(+80 mV) EC50 (nM) 358. 2 ± 28.8 293.73 ± 70.1 
 
 
Figure 28: (A) Mean outward current densities over time in intracellular 1 µM Ca2+ TRPC5-stably 
transfected HEK 293 cells. Cells were non-treated (TRPC5 stable) or incubated in 100 ng/ml 
epidermal growth factor for 4 min at 37°C (EGF), incubated in 10 µM Cytochalasin D for 10 min 
at 37°C (Cyt D) and in 2 µM U73122 for 5 min at 37°C (U 73122), followed by  perfusion with 200 
µM carbachol (CCH). (B) Average peak current densities for TRPC5 currents activated by 
different intracellular Ca2+ concentrations in TRPC5 stable cells treated as described in (A) or 
perfused with 200 µM carbachol (CCH). Same experiments as in Fig. 26. 
 
Finally, I tested whether rearrangements of the cytoskeleton or activation of PLC are 
involved in the activation of TRPC5 currents by internal Ca2+. As shown in Fig. 28 A, 
TRPC5 cells treated with 10 µM cytochalasin D showed a fast outward current 
development in the presence of 1 µM internal Ca2+ that was comparable to the 
response of non-treated TRPC5 cells. Similarly, in whole cell recordings, TRPC5 
cells pre-incubated in 2 µM U73122 developed TRPC5 currents following exogenous 
application of 1 µM Ca2+ through the patch pipette (Fig. 28 A). Thus, the presented 
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results (Fig. 28 A) indicated that neither PLC nor the cytoskeleton appeared to be 
involved in the activation of TRPC5 channels by internal Ca2+. 
In summary, additive effects of EGF and CCH were seen at concentrations of 100 nM 
Ca2+ (Fig. 28 B). Furthermore, EGF and CCH were not effective in inducing TRPC5 
currents at zero [Ca2+]i suggesting that a rise of internal [Ca2+]i is the ultimate signal 
for activation of TRPC5 channels under stimulation of membrane receptors.  
 
4.3.4 Role of calmodulin-binding site in the Ca2+-dependent activation 
of TRPC5 channels 
 
Two calmodulin (CaM)-binding sites named CaM / IP3R-binding (CIRB) domain and 
calmodulin-binding domain II (CBII) were identified at the C-terminus of TRPC5 
proteins61, 62. Therefore, it was tested whether these calmodulin-binding sites were 
involved in the activation of TRPC5 channels by internal Ca2+. HEK 293 cells 
transiently transfected with a TRPC5 mutant that contains a triple amino acid 
substitution in the CIRB domain (J1305) did not show a detectable TRPC5 current in 
response to increased intracellular Ca2+ levels (Fig. 29 A, B). In contrast, 1 µM 
intracellular Ca2+ activated TRPC5 currents in HEK 293 cells transfected with a 
mutated form of the TRPC5 protein lacking the CBII (J1307) (Fig. 29 A, B). Activated 
TRPC5 currents in J1307 transfected cells showed the TRPC5 typical I-V-
characteristic, whereas in HEK 293 cells transfected with J1305 only linear leak 
currents were detectable (Fig. 29 C). Thus, these results indicated that CBII is not 
required for the action of internal Ca2+ on TRPC5 channels. Conversely, CIRB might 
be responsible for the activation of TRPC5 channels by internal Ca2+. 
 
Figure 29: Intracellular Ca2+ (1 µM) activated TRPC5 currents in HEK 293 cells overexpressing 
CIRB mutated TRPC5 (J1305; white circles; n = 5) or CBII deleted TRPC5 (J1307; black circles; 
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n = 6). (A) Average outward current densities were recorded at +80 mV. (B) Corresponding 
inward current densities at -80mV. (C) Representative I-V-characteristic for peak current 
recorded in J1307 and J1305 transfected HEK 293 cells.  
 
4.3.5 Intracellular Ca2+ release results in TRPC5 dependent membrane 
depolarization    
 
In the experiments shown in Fig. 18 – 29, the whole-cell configuration of the patch-
clamp technique was used to record TRPC5 channel currents under tight control of 
the ion composition of the cytosol. In the next series of experiments, the activation of 
TRPC5 channels is explored in intact cells. For this purpose, it was tested whether 
the increase of [Ca2+]i by Ca2+-store depletion activates TRPC5 channels in the 
TRPC5 cell line. Since the activation of the non-selective TRPC5 ion channels might 
result in membrane depolarization, fluorometric measurements of the membrane 
potential and Ca2+ signalling were performed in the TRPC5 cell line and also in HEK 
293 control cells (Fig. 30). The change in the membrane potential in response to  
1 µM thapsigargin and 130 µM carbachol was tracked. Thapsigargin perfusion 
induced membrane depolarization in TRPC5 stable cells whereas HEK 293 cells 
remained at basal membrane potential levels (Fig. 30 A). The Ca2+ signals measured 
in TRPC5 cells were inistinguishable from Ca2+ signals in HEK 293 control cells (Fig. 
30 C). Notably, carbachol perfusion induced a strong and fast membrane potential 
depolarization in both TRPC5 stable and HEK 293 cells with a 50 % stronger signal 
in TRPC5 stable cells (Fig. 30 B). In contrast to the indistinguishable [Ca2+]i rise in 
thapsigargin-treated cells,  the Ca2+ signals recorded in carbachol-treated cells were 
stronger in TRPC5 cells than in HEK 293 control cells (Fig. 30 C, D). Carbachol was 
always effective independently from the experimental design, whereas membrane 
depolarization and Ca2+ signals induced by thapsigargin could hardly be monitored 
when applied after carbachol perfusion (Fig. 30).  
 
In conclusion, Charbachol-induced membrane depolarization was detectable in 
TRPC5 cells and also HEK 293 control cells. By contrast, TRPC5 dependent 
membrane depolarization was recorded exclusively in the TRPC5 cell line triggered 
by thapsigargin. Under non-buffered intracellular conditions   the [Ca2+]i rise induced 
by the thapsigargin via Ca2+-store depletion activated TRPC5 channels.  
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Figure 30: Fluorometric measurements of membrane potential and Ca2+ imaging in the TRPC5 
cell line (TRPC5 stable; black) and HEK 293 control cells (HEK 293: grey). Store-depleting 
reagent thapsigargin (TG; 1 µM) and 130 µM muscarinic-receptor agonist carbachol (CCH) were 
applied as indicated above graph. (A, B) Cells were incubated with standard external solution 
(HBSS) containing the FLIPR® dye for 15 min at room temperature (RT). Cells were monitored 
by exciting FLIPR® dye at 530 nm and the emitted fluorescence was recorded at 600 nm. The 
bath solution (HBSS) contained (in mM): 1.26 Ca2+, 5.36 K+, 136.89 Na+ (see Materials and 
Methods). Before and after each experiment, unspecific background fluorescence was 
measured by exciting at 350 nm. (C, D) Cells were loaded with FURA-2AM (10 µM) for 40 min at 
RT and then washed twice with HBSS. Individual cells were monitored exciting FURA-2 at 340 
nm and 380 nm and recording emitted fluorescence at 510 nm. Non-specific background 
fluorescence was subtracted from displayed ratio F340/F380. At least two independent 
experiments were performed. For each experimental setting, the signals of individual cells (n: 
46 – 83) were pooled to obtain average FLIPR® and FURA-2 signals. 
  
To further test whether the thapsigargin-induced [Ca2+]i rise is inducing the 
membrane depolarization in the TRPC5 cell line, membrane potential changes and 
Ca2+ signals were recorded simultaneously. TRPC5 cells were loaded with FURA-
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2AM and the membrane potential dye FLIPR®. In the presence of extracellular Ca2+ 
(1.26 mM) the membrane potential depolarized in response to thapsigargin and Ca2+ 
signals increased as well (Fig. 31, A). As a control for a proper function of the 
membrane potential dye and visualization of the actual cell condition, I perfused the 
cells with a high K+ solution (25 mM) at the end of each experiment. These 
experiments were designed to investigate whether the Ca2+ signals precede the 
membrane potential depolarization. As illustrated in Fig. 31, Ca2+ signals in TRPC5 
cells revealed a fast increasing Ca2+ signal, followed by a depolarization of the 
membrane potential carried by TRPC5 channels. The Ca2+ increase reached the half 
maximum signal strength (t1/2) after 33.8 ± 0.98 s and the membrane potential at 55.9 
± 4.57 s after thapsigargin perfusion (Fig. 31, B). In order to prove that the delay in 
depolarization in comparison to Ca2+ increase was not due to the inertia of the 
membrane potential dye, the depolarization signal in response to high extracellular 
K+ was measured. Half maximal signal strength was reached rapidly, only 4.55 ± 0.28 
s after perfusion (Fig. 31 B). Comparable results were obtained under extracellular 
Ca2+-free conditions (Fig. 31 C). Ca2+ signals increased to half maximum within 53.0 
± 2.38 s in response to thapsigargin perfusion followed by membrane depolarization 
due to TRPC5 activation (t1/2 = 75.08 ± 0.98 s) (Fig. 31 D).  
Thus, Ca2+ signals preceded membrane depolarization in the TRPC5 cell line, 
indicating, that the [Ca2+]i rise induced by thapsigargin activated TRPC5 channels, 
which in turn induced a membrane depolarization. 
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Figure 31: Comparison of the time course of membrane potential and [Ca2+]i changes. 
Fluorescence videomicroscopy was used to track membrane potential changes and Ca2+ 
signals simultaniously. TRPC5 cells were incubated for 40 min at RT in FURA-2AM (10 µM), 
washed and incubated for 15 min in FLIPR® dye. Same experimental procedure as previously 
described in Fig. 30.  Corresponding filtersets and excitation wavelengths were controlled by 
macros (see Materials and Methods). FURA-2 signals are given as black circles, FLIPR® 
tracking is indicated as white circles. Numbers of cells: n: 43-72. (A, C) Time courses of 
membrane potential and [Ca2+]i changes in cells bathed in HBSS containing 1.26 mM Ca2+ and 
in a Ca2+-free solution, respectively. As indicated, 1 µM thapsigargin (TG) and high K+ solution 
(high K+) are perfused. (B, D) Normalized FURA-2 (black circles) and FLIPR® signals in 
response to 1 µM TG (white circles) or high K+ (25 mM; grey circles) in TRPC5-stably 
transfected HEK 293 cells. Embedded bar graphs display the time to half maximum signal 
strength.   
 
4.3.6 L-type Ca2+ channels act as Ca2+ donors for TRPC5 activation 
 
Voltage-gated Ca2+ channels represent an important source for cellular Ca2+ influx in 
excitable cells, similar to the function of ORAI and STIM1 dependent CRAC currents 
in non-excitable cells. Voltage-gated Ca2+ channels are formed as a complex of 
different subunits: α1, α2δ, β1-4 and γ103. The subunit α1 forms the ion conducting pore 
while the associated subunits have several functions including the modulation of 
 72
gating. In TRPC5-stably transfected HEK 293 cells overexpressing the α1C subunit of 
the L-type Ca2+ channel plus the β2 subunit, inward (at -60 mV) and outward TRPC5 
current development (at +80 mV) was clearly detectable when Ca2+ influx (at 0 mV) 
was activated by depolarizing the cell membrane of TRPC5 cells (Fig. 32 A). 
 
 
Figure 32: (A, B) Whole cell recordings reveal TRPC5 ion current development (at -60 and +80 
mV) and L-Type channel-dependent Ca2+ currents (at 0 mV) in TRPC5 stable cell line 
overexpressing α1C- and β2-subunits of L-Type Ca2+ channels. Time courses for outward (+80 
mV) and inward currents (-60 mV) are shown for the TRPC5 cell line (grey circles; n = 6) and for 
transient transfections of α1C- and β2-channel proteins in the TRPC5 cell line (black circles; n = 
5) and in non-transfected HEK 293 cells (white circles; n= 4). Current densities were monitored 
by applying a voltage step protocol shown in (C). (C) Representative I-V-ion current traces 
taken at indicated time points during experiment (black arrows in (A)). Applied voltage step 
protocol is displayed. (D) Representative I-V-characteristics for L-type-overexpressing TRPC5 
stable cells recorded before (black circles) and after (grey circles) TRPC5 channel activation 
recordings from (A). Step protocols were applied as indicated. 
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In these experiments, it was tested whether L-type Ca2+ channels can provide 
sufficient Ca2+ influx to activate TRPC5 channels as it was previously shown for 
CRAC channels (Fig. 21). In the presence of 5 mM extracellular Ca2+, inward and 
outward currents activated in TRPC5 cells transiently transfected with the α1C plus β2 
subunits approximately 100 s after establishing the whole-cell configuration under 
intracellular buffered Ca2+ conditions (10 mM EGTA). A voltage-step protocol was 
applied every 2 s, to activate the voltage-gated L-type channels resulting in Ca2+ 
influx (recorded at 0 mV) (Fig. 32 B). These VGCC dependent Ca2+ currents showed 
an inactivation over time in TRPC5 cells overexpressing the VGCC subunits as well 
as in HEK 293 control cells transfected with the α1C plus β2 subunits. Ca2+ currents 
were not detectable in non-transfected TRPC5 stable cells (Fig. 32 B). The inward 
and outward current development at -60 mV and +80 mV, respectively, were 
exclusively observed in TRPC5 stable cells which show a clear Ca2+ influx through L-
type channels. Neither HEK 293 control cells revealing Ca2+ influx currents through L-
type channels nor non-transfected TRPC5 stable cells lacking Ca2+ signals showed 
detectable inward and outward current activation (Fig. 32 A, B). As illustrated in Fig. 
32, TRPC5 stable cells overexpressing the α1C subunit of L-type Ca2+ channels plus 
the β2 subunit showed clear Ca2+ influx at 0 mV which is inactivating over time. 
Notably, inward (at -60 mV) and outward currents (at +80 mV) which developed over 
time revealed the expected TRPC5 current-voltage characteristics (Fig. 32 D). Thus, 
non-selective TRPC5 currents were activated by a local [Ca2+]i rise which is 
generated by Ca2+-influx through L-type Ca2+ channels. Thus, the present 
experiments suggest that L-type Ca2+ channels represent a signaling pathway for 
TRPC5 activation in excitable cells. 
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5 Discussion 
 
5.1 Murine ORAI variants form functional CRAC channels 
 
Recent experiments have put forward that ORAI and STIM represent the molecular 
components of CRAC currents11, 83. The ER membrane-located proteins STIM1 and 
STIM2 appear to act as Ca2+ sensors with a C-terminal EF-hand motif reaching into 
the ER lumen. Latest reports revealed that STIM2 activates Ca2+ influx upon smaller 
decreases in ER Ca2+ levels 29 and also mediates store-independent Ca2+ influx104. 
However, STIM1 seems to play the major role in CRAC current activation. Upon store 
depletion, STIM1 relocalizes into punctae and STIM1 / STIM1 multimerization occurs 
followed by STIM1/ORAI interaction activating the Ca2+ entry through ORAI protein 
complexes105.  
ORAI proteins, however, are believed to be located in the plasma membrane of a cell 
and exhibit the CRAC channel itself by forming multimeric assemblies33. The 
replacement of conserved glutamate residues in the first and third transmembrane 
segments as well as aspartate to arginine substitution in the first extracellular loop of 
ORAI change the ion selectivity characteristics of CRAC currents. This change in ion 
selectivity provides good evidence that ORAI proteins forming the CRAC channel 
pore33. So far, most investigations have been performed either with human or 
Drosophila isoforms106. 
Here, I determined the functional properties of CRAC currents activated by 
intracellular dialysis of IP3 in either HEK 293 or RBL 2H3 cells transiently transfected 
with murine STIM1 and murine ORAI1, ORAI2L or ORAI2S (Section 4.1). Murine 
ORAI1 in combination with STIM1 induced large, strongly inward rectifying currents in 
HEK 293 and RBL 2H3 cells, independent of endogenously expressed ORAI 
proteins, respectively. Similar findings were reported for human and Drosophila 
STIM1/ORAI conducted currents106. Since HEK 293 and RBL 2H3 cells differ in their 
endogenous STIM and ORAI expression, the recorded CRAC currents triggered by 
intracellular IP3 differ in current density as well. Low STIM and ORAI expression in 
HEK 293 cells resulted in a hardly detectable CRAC current, whereas clearly inward 
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rectifying currents were recorded in RBL 2H3 cells displaying detectable endogenous 
ORAI1, ORAI2 and STIM1 expression (Section 4.136). 
 
Overexpression of ORAI2 variants induced CRAC current densities which were 
smaller than those induced by ORAI1 in HEK 293 cells under identical experimental 
conditions (Fig. 11, A). Since STIM1 was co-overexpressed in each experiment, the 
difference in current density might result from the ability of ORAI to interact with 
STIM1. Since the main difference between the ORAI variants, especially ORAI1 and 
ORAI2S, resides in the length of the N-terminus, these results suggest an important 
role for the N-terminus of ORAI proteins. However, Muik et al.105 recently reported 
that the dynamic coupling of STIM1 and ORAI1 occurs at the C-terminus of ORAI 
proteins but the CRAC current development highly depends on an intact N-terminus, 
which was originally shown for human Scid patients and is also true for ORAI1 and 
ORAI2S proteins with a arginine to tryptophan substitution at position 91 or 78, 
respectively (Fig. 16). These findings lead to the conclusion that the ORAI N-terminus 
is responsible for proper channel gating. Furthermore, CRAC current densities of 
RBL 2H3 cells overexpressing STIM1 and ORAI2 variants did not exceed current 
densities recorded in RBL 2H3 cells transiently transfected with STIM1 alone (Fig. 
11, B). Thus, the capability of ORAI2L and ORAI2S to form recombinant CRAC 
channels depends on the cell background in which these proteins are expressed. In 
conclusion, ORAI2 isoforms, including the endogenously non-expressed ORAI2S 
(N130Y) variant, substitute ORAI1-dependent CRAC currents only partly (Fig. 15).  
Additionally, STIM1 and the GAMMA1 or GAMMA2 subunit of voltage-gated Ca2+ 
channels were co-overexpressed in HEK 293 as well as in RBL 2H3 cells. Similarities 
in the tertiary structure35 inspired these comparative experiments but neither cells co-
transfected with STIM1 and GAMMA1 or GAMMA2 nor GAMMA1 or GAMMA2 alone 
transfected cells exhibited altered current densities in comparison to STIM1 
expressing cells or endogenous CRAC currents. Thus, GAMMA subunits cannot 
substitute ORAI proteins for proper SOCE.  
IP3-induced CRAC currents in non-transfected RBL 2H3 cells display several 
hallmarks which are also exhibited in STIM1 plus ORAI variants-expressing RBL 2H3 
cells. As seen in Fig. 13, CRAC channels are highly Ca2+ selective and conduct 
inward rectifying currents. Under extracellular Ca2+ and Mg2+-free conditions, 
endogenous CRAC channels and recombinant CRAC channels, formed by murine 
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ORAI1, ORAI2L or ORAI2S, conduct Na+ ions and do not show a detectable current 
by removing extracellular Ca2+. These features, originally described for CRAC 
currents in 199321, give another evidence for STIM1 and ORAI as functional CRAC 
channel-forming proteins. 
In addition, the influence of intracellular Ca2+ on the CRAC currents in STIM1 plus 
ORAI transfected cells was investigated. Comparison of CRAC inactivation in 
dependence on the Ca2+ chelators EGTA and BAPTA on the inactivation of CRAC 
currents in HEK 293 cells overexpressing STIM1 plus ORAI1 or ORAI2 variants, led 
to the conclusion that CRAC channels formed by ORAI proteins undergo an 
intracellular Ca2+-dependent inactivation. This inactivation is proportional to the level 
of CRAC current density and, thus, to the levels of recombinant CRAC channels 
expressed in HEK 293 cells (Fig. 12). Accordingly, the degree of CRAC current 
inactivation and its inhibition by BAPTA was also dependent on the cells individual 
levels of recombinant CRAC channel expression. However, the inhibition of CRAC 
current inactivation by BAPTA had no influence on the maximum current densities 
recorded in HEK 293 cells cotransfected with STIM1 and ORAI1 or ORAI2L. HEK 
cells overexpressing STIM1 plus ORAI2S showed enhanced maximum current 
densities under intracellular BAPTA conditions. Thus, it appears that ORAI2S is more 
sensitive to inactivation by intracellular Ca2+ than ORAI2L or ORAI1, respectively.  
In triple transfection experiments overexpressing STIM1, ORAI1 and ORAI2S, 
smaller current densities were recorded than in cells overexpressing STIM1 plus 
ORAI1 (Fig. 14). A similar observation was not made in cells transfected with STIM1, 
ORAI1 plus ORAI2L. Thus, it appears that ORAI2S plays a dominant-negative role in 
the formation of functional CRAC channels by ORAI1 proteins giving rise to the 
assertion that heteromultimeric CRAC channels exist, consisting of both ORAI1 and 
ORAI2 proteins. In addition, ORAI2L or ORAI2S transfected RBL 2H3 cells had 
smaller current densities in comparison to endogenous ICRAC (Fig. 11) leading to the 
conclusion that endogenous ICRAC is mainly carried by ORAI1 homomultimers. When 
recombinant ORAI2 variants are expressed, heteromultimeric assemblies occur and 
current density decreases. The possibility to form heteromultimeric channels seems 
to be a good mechanism to control and specify Ca2+ entry.   Vig et al.33 reported 
multimeric assemblies of ORAI proteins suggesting homomultimeric as well as 
heteromultimeric protein complexes. 
 
 77
In addition to reports from several groups working on SOCE and CRAC, my 
investigations suggest that STIM1 and ORAI1, ORAI2L and ORAI2S reconstitute 
CRAC currents in cell systems overexpressing STIM1 plus an ORAI variant. STIM1 
appears to play a role as an ER membrane-located Ca2+ sensor that is translocated 
and rearranged into punctae in close proximity to the plasma membrane in response 
to store depletion31. A dynamic coupling105 activates the multimeric ORAI channel 
complex and CRAC currents develop. In conclusion, proteins form heteromultimeric 
CRAC channels and the resultant current densities appear to be dependent on the N-
terminus of ORAI proteins.       
The importance of the ORAI N-terminus was described first in 2006 when Feske et 
al.8 discovered a single amino acid mutation at position 91 of ORAI1 leading to an 
abrogated Ca2+ entry in T cells derived from SCID patients. In HEK 293 cells 
overexpressing STIM1 plus murine ORAI1 or ORAI2S proteins possessing a single 
point mutation (ORAI1 Scid, ORAI2S Scid) that was introduced according to the 
human SCID mutation, CRAC currents were not detectable (Fig. 16). Moreover, 
single HEK 293 cells either transfected with ORAI1 Scid or ORAI2S Scid showed 
reduced ICRAC compared to endogenous CRAC, providing additional evidence for a 
functional interaction or heteromultimeric assembly between ORAI protein variants. 
 
Here, my investigations provide strong evidence that murine STIM1 and ORAI 
variants represent the molecular components of the CRAC current showing all the 
hallmark features of ICRAC originally discovered in mast cells21. Upon store-depletion 
STIM1 is responsible for the signal transduction to the ion channel forming ORAI 
proteins. Channel gating is controlled by the N-terminus of ORAI proteins. 
 
Although the presented data is very compelling with respect to the molecular 
components of CRAC currents, investigations are still limited to hematopoietic cells 
due to the fact that CRAC currents are hardly detectable in non-hematopoietic cells. 
As extensively documented in Wissenbach et al., 2007, STIM and ORAI proteins are 
expressed in a vast array of different cell types. In both, lymphocytes and mast cells 
CRAC currents were first described and characterized, and STIM1 and ORAI protein 
expression was reported21, 22. As previously shown in Fig. 10 and 11, the molecular 
components for CRAC currents seem to be revealed by the fact that STIM1 plus 
ORAI-transfected cells exhibit inwardly rectifying currents in response to store 
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depletion independent of the cell background. Fig. 33 illustrates the ICRAC activation in 
response to store-depletion with the store Ca2+ sensor STIM1 and the multimeric, 
pore-forming ORAI proteins as molecular components of CRAC channels. 
  
Figure 33: Activation mechanism of CRAC currents. The pore-forming ORAI protein complex 
(ORAI multimer) is located in the plasma membrane. The Ca2+-sensor stromal-interacting 
molecule 1 (STIM1) is randomly distributed in the membrane of the endoplasmic reticulum 
(ER), the major intracellular Ca2+-store. (A) IP3 is binding to the IP3-receptor (IP3R). (B) Upon 
IP3R stimulation, Ca2+ is depleted and STIM1 proteins assemble to multimers. (C) Multimeric 
STIM1 complexes interact with the multimeric ORAI complex and ICRAC activates. Illustration 
modified from Muik et al., 2008105.   
 
In clear contrast to the present findings that STIM1 and ORAI proteins reconstitute 
ICRAC, cortical neurons displaying a clearly detectable ORAI expression did not show 
any Ca2+ inward current in response to store-depleting reagents such as IP3, 
ionomycin or 4-BrA23187. Whole cell recordings could only display voltage-gated 
Na+ currents which were used as identification critera for cortical neurons besides 
GAD67 amplification (Fig. 17). These results leave room for different interpretations. 
First, cortical neurons may express non-functional ORAI proteins for instance 
proteins containing critical mutations at the N-terminus or at the C-terminus changing 
the coiled-coil region being essential for STIM1 and ORAI interaction105. Another very 
simplistic interpretation might be that neither STIM1 nor ORAI nor even both proteins 
are sufficiently expressed, so that current densities are just below detectable levels. 
A third and most provocative interpretation implicates a third molecular component 
required to generate SOCE, at least in non-hematopoietic cells. The second part of 
my thesis addresses this highly discussed model elucidating the wide field of SOCE, 
CRAC and TRPC ion channels. 
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5.2 Functional coupling of TRPC5 and Ca2+-selective ion 
channels  
 
TRPC ion channels are believed to participate in store-operated Ca2+ entry. As 
described in this study, STIM1 and ORAI proteins have been proposed to form 
functional SOCE channels. Consequently, I investigated whether TRPC channels 
participate in SOCE that is dependent on or regulated by STIM1  
and / or ORAI proteins.  
In triple transfection experiments, HEK 293 cells overexpressing STIM1, ORAI1 and 
TRPC3 or TRPC5 ion channels showed additional outward current development 
which was not detectable in HEK 293 cells co-transfected with STIM1 and ORAI1 
alone. Outward current activation was accompanied by increasing inward currents 
leading to the conclusion that another current component adds to the CRAC current 
in response to intracellular dialysis of IP3 (Fig. 18). Interestingly, the TRPC-
dependent current activation via store-depletion was dependent on STIM1 and 
ORAI1 proteins. TRPC5-transfected HEK 293 cells did not exhibit any IP3-evoked 
currents and neither did STIM1 plus TRPC5-transfected cells nor ORAI1 plus 
TRPC5-transfected cells. The same is true for TRPC3. In contrast to recent reports96, 
97, SOCE was neither detectable nor increased in TRPC3-overexpressing HEK 293 
cells co-transfected with ORAI1. 
Thus, STIM1, ORAI1 and TRPC proteins appear to functionally interact with each 
other since TRPC channels show a response to store-depletion that is exclusively 
detectable in triple-transfected cells. Based on the hypothesis that either the CRAC 
current-dependent Ca2+ signal or a direct protein-protein interaction between STIM1, 
ORAI1 and TRPC channels are responsible for the initial results, I focused on TRPC5 
ion channels and their activation mechanism.   
TRPC5 was originally reported as a SOCE13 channel whereas receptor activation via 
the PLC pathway is the common activation mechanism reported so far55. As 
mentioned above, IP3-evoked TRPC5 currents were only detectable in cells 
overexpressing STIM1 and ORAI1 leading to CRAC currents in response to store-
depletion under extracellular 5 mM Ca2+ containing conditions. As seen in Fig. 20, 
whole-cell current recordings over time resolved an initial inward rectifying current 
followed by additional outward and inward current activation. Moreover, the reversal 
potential shifts from a typical CRAC current of +50 mV to +5 mV, which is 
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characteristic of TRPC5 currents. Additionally, the TRPC5 Mg2+ block95 between  
+5 mV and approximately +30 mV gives a further evidence for TRPC5 activation 
under described conditions. In contrast, TRPC5 currents did not develop in response 
to intracellular IP3 when Ca2+ was removed from the external solution. However, 
TRPC5 currents were activated when cells were reperfused with a 5 mM Ca2+-
containing external solution. Similar results were observed in TRPC5 cells 
overexpressing STIM1 and non-functional ORAI1 Scid proteins lacking the Ca2+ 
influx into the cytosol (Fig. 21).  
Therefore, the functional interaction of CRAC currents and TRPC5 appears to 
depend on the Ca2+ influx carried by functional and STIM1 activated ORAI1 channel 
complexes. Fig. 22 shows, that TRPC5 currents did not activate when intracellular 
Ca2+ levels were controlled by the fast Ca2+ chelator BAPTA, instantaneously 
chelating Ca2+ influx in close proximity to the plasma membrane. The fact that larger 
CRAC currents result in stronger TRPC5 activation leads to the conclusion that 
TRPC5 activation depends on local Ca2+ influx (Fig. 23).  
Subsequently experiments were performed under extracellular Ca2+-free conditions 
and I provided defined amounts of free intracellular Ca2+ concentrations buffered by 
10 mM EGTA in TRPC5-stably transfected HEK 293 cells. These experiments 
revealed that TRPC5 is activated in a dose-dependent manner by cytosolic Ca2+ 
levels. I determined EC50 = 358 nM free Ca2+ for outward current development and 
EC50 = 635 nM for inward currents carried by TRPC5 proteins. The phenomenon that 
TRPC5 channels show distinct gating properties called `phases´ was described in 
TRPC5-transfected HEK 293 cells receptor-activated by histamine107. Accordingly, 
the properties of TRPC5 channels change from outward-rectifying to double-rectifying 
I-V-shapes during current development over time107. Here, I observed similar 
biophysical properties dependent on intracellular Ca2+ concentrations. As mentioned 
above, EC50 of the outward currents is 45 % lower than EC50 for inward currents 
mediated by TRPC5 meaning that outward rectifying currents develop in response to 
lower intracellular Ca2+ levels followed by inward current development (Fig. 24). The 
ratio between inward currents and outward currents increase in proportion to the 
provided intracellular Ca2+ concentration (Fig. 24).  
Even in TRPC5 stable HEK 293 cells transfected with murine STIM1, outward current 
development precedes inward current development showing similar `phases´ as non-
transfected TRPC5 cells do. But more interestingly, the overall current activation is 
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shifted to 30 % lower intracellular Ca2+ levels for both outward and inward currents in 
the presence of recombinant STIM1. Several publications have reported an 
interaction of TRPC ion channels and STIM154, 66, 97 and my observations at least 
reveal a modulatory effect by STIM1 on TRPC5 activation (Fig. 24) in addition to a 
significant delay in current desensitization in STIM1-overexpressing TRPC5 stable 
cells compared to non-transfected TRPC5 stable cells (Fig. 25). 
The present experiments suggest that TRPC5 currents develop in response to 
increasing cytosolic Ca2+ levels with STIM1 shifting the current activation to lower 
intracellular Ca2+ concentrations showing a modulatory effect on TRPC5 channels. 
The importance of intracellular Ca2+ levels for TRPC5 activation has been eagerly 
discussed for years, but so far a simple and direct Ca2+ dependence has not been 
shown.  
As shown in Fig. 26, carbachol activation strongly depends on intracellular Ca2+ 
levels. No current development was detectable in response to CCH perfusion when 
internal Ca2+ levels were buffered to 0 nM (Fig. 26). Physiological concentrations 
(100 nM) of intracellular Ca2+ were prerequisite for CCH-induced TRPC5 activation. 
Additionally, CCH perfusion could enhance TRPC5 currents activated by increased 
intracellular Ca2+ levels. In particular, inward currents did more than double in size 
whereas outward currents showed a decent 50 % current boost (Fig. 26) in response 
to CCH perfusion. In contrast, Ca2+-activated TRPC5 currents did not show any 
reduction in size when treated with U73122, a PLC inhibitor, leading to the 
conclusion that receptor stimulation can increase current densities but the PLC 
pathway activation does not play an essential role in TRPC5 development.  
Similar results were obtained when TRPC5 stable cells were incubated with EGF to 
stimulate the fusion of TRPC5-containing secretory vesicles with the plasma 
membrane60. Since more TRPC5 channels are incorporated into the plasma 
membrane following EGF stimulation and, moreover, EGF may support current 
activation, TRPC5 stable transfected cells showed a small shift to lower Ca2+ 
concentrations and bigger current densities. Cytochalsin D incubation, which 
prevents secretion by inhibiting the rearrangement of the cytoskeleton, did not 
change TRPC5 activation by intracellular Ca2+ at all. 
These results provide additional evidence that TRPC5 is activated by increased Ca2+ 
levels. Most Ca2+ signals are prevalently mediated to acceptor proteins  
via Ca2+-calmodulin complexes. Ca2+ binds to the EF hand motif of calmodulin 
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priming specific calmodulin binding sites which can then mediate the Ca2+ signaling 
to other proteins. For instance, TRPC5 with a mutation in its calmodulin binding sites 
were activated by 1 µM intracellular Ca2+. CBII mutants (J1307) showed unaltered 
current developments in comparison to current development recorded in WT TRPC5 
HEK 293 cells. The CIRB site mutants (J1305), however, did not exhibit TRPC5 
currents in response to 1 µM intracellular Ca2+. These results agree with the absence 
of TRPC5 currents in receptor-activated CIRB site mutants62. A reduction in Ca2+ 
entry as reported for CBII mutants62 could not be confirmed since Ca2+-activated CBII 
mutants did not show a reduction in the recorded current density (Fig. 29).  
In conclusion, the CBII binding site of TRPC5 does not play a role in Ca2+-dependent 
TRPC5 activation whereas the CIRB site mutations abolished TRPC5 current 
activation. The question remains whether CIRB site mutants represent functional ion 
channels at all, since they showed neither CCH-induced nor intracellular Ca2+-
activated TRPC5 currents.  At present, it is not clear whether CCH activation of 
TRPC5 is due to Ca2+ release from intracellular stores and, thus, increasing Ca2+ 
levels or whether an alternative pathway (for instance via IP3 or DAG interaction) is 
involved.  Final conclusions about a Ca2+-calmodulin activation and the described 
current boost mediated by CCH perfusion remain fragmentary and will be subject of 
further investigations. 
 
Originally described as a store-operated ion channel, my investigations show that 
TRPC5 is activated by increasing cytosolic Ca2+ levels. Since store-operated Ca2+ 
entry channels are strictly defined as ion channels activated by store depletion in 
buffered intracellular conditions17, TRPC5 does not belong to the group of SOCE 
channels in contrast to ORAI proteins. However, TRPC5 is activated in response to 
thapsigargin (TG) perfusion in fluorescence-imaging experiments recording 
membrane potential changes (Fig. 30). TG-induced membrane changes are due to 
TRPC5 activation, whereas CCH induces Ca2+ signals in addition to membrane 
depolarization in both TRPC5 stable HEK 293 and WT HEK 293 cells (Fig. 30). 
Under non-buffered intracellular conditions, store-depletion activated TRPC5 
channels as a result of increasing intracellular Ca2+ levels. The Ca2+ rise clearly 
precedes membrane depolarization (Fig. 31) providing further evidence that TRPC5 
is another Ca2+-activated member of the TRP family.           
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As mentioned before, a local Ca2+ rise conducted by CRAC currents can induce 
TRPC5 current development. Na+ and Ca2+ influx through TRPC5 channels 
depolarize the membrane potential reducing the driving force for Ca2+ influx through 
CRAC channels. Thus, Ca2+-activated TRPC5 currents may play a role in negative 
feedback for SOCE in mast cells which express STIM and ORAI proteins in addition 
to TRPC5. 
Moreover, voltage-gated Ca2+ channels (VGCCs), here L-type Ca2+ channels, can 
also act as a Ca2+ donor. Illustrated in Fig. 32, TRPC5 current development occurs in 
response to Ca2+ influx mediated by voltage-gated channels. Thus, in excitable cells 
frequent action potentials (APs) may generate high local Ca2+ accumulation that 
activates TRPC5 currents resulting in sustained depolarization. Further conclusions 
are very speculative, but however, strong expression of TRPC5 proteins in 
hippocampus neurons could play a major role for intracellular Ca2+ signaling being 
essential for neurotransmitter release.  
 
In conclusion, TRPC5 proteins may play a modulating role in cellular Ca2+ signalling. 
As a Ca2+-activated non-selective ion channel, it is sensitive to local Ca2+ changes 
due to Ca2+ influx or Ca2+ store depletion. TRPC5 activation leads to membrane 
depolarization, thus, resulting in a very sensitive and precise way of feedback 
mechanism to establish specific Ca2+ signals (Fig. 34).  
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Figure 34: Ca2+ activated TRPC5 channels play a central role in cellular Ca2+ signaling. 
`Donor´channels such as ORAI or voltage-gated Ca2+ channels (VGCC) may provide the 
required local Ca2+ rise to activate non-selective TRPC5 channels. STIM1 may modulate 
channel activity but TRPC5 does not act as a typical SOCE channel. The response to store-
depleting reagents is a secondary effect based on local Ca2+ increase due to CRAC currents or 
release from intracellular stores.  
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